<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26445137</article-id><article-id pub-id-type="pmc">4596478</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0139261</article-id><article-id pub-id-type="publisher-id">PONE-D-15-27690</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Feasibility and Preliminary Efficacy of Visual Cue Training to Improve Adaptability of Walking after Stroke: Multi-Centre, Single-Blind Randomised Control Pilot Trial</article-title><alt-title alt-title-type="running-head">VCT for Adaptable Walking after Stroke: Pilot Trial</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hollands</surname><given-names>Kristen L.</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref><xref rid="cor001" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Pelton</surname><given-names>Trudy A.</given-names></name><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Wimperis</surname><given-names>Andrew</given-names></name><xref ref-type="aff" rid="aff003">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Whitham</surname><given-names>Diane</given-names></name><xref ref-type="aff" rid="aff004">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Tan</surname><given-names>Wei</given-names></name><xref ref-type="aff" rid="aff004">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Jowett</surname><given-names>Sue</given-names></name><xref ref-type="aff" rid="aff005">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Sackley</surname><given-names>Catherine M.</given-names></name><xref ref-type="aff" rid="aff006">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Wing</surname><given-names>Alan M.</given-names></name><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Tyson</surname><given-names>Sarah F.</given-names></name><xref ref-type="aff" rid="aff007">
<sup>7</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Mathias</surname><given-names>Jonathan</given-names></name><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hensman</surname><given-names>Marianne</given-names></name><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>van Vliet</surname><given-names>Paulette M.</given-names></name><xref ref-type="aff" rid="aff008">
<sup>8</sup>
</xref></contrib></contrib-group><aff id="aff001">
<label>1</label>
<addr-line>School of Health Sciences, University of Salford, Allerton Building, Salford, M6 6PU, United Kingdom</addr-line>
</aff><aff id="aff002">
<label>2</label>
<addr-line>Colleges of Life and Environmental Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, United Kingdom</addr-line>
</aff><aff id="aff003">
<label>3</label>
<addr-line>Birmingham Community Health Care NHS Trust, (BCHCT), Moseley Hall Hospital, Birmingham, B13 8JL, United Kingdom</addr-line>
</aff><aff id="aff004">
<label>4</label>
<addr-line>University of Nottingham, Nottingham Clinical Trials Unit, Nottingham Health Science Partners, C-floor, South Block, Queen&#x02019;s Medical Centre, Nottingham, NG7 2UH, United Kingdom</addr-line>
</aff><aff id="aff005">
<label>5</label>
<addr-line>College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, United Kingdom</addr-line>
</aff><aff id="aff006">
<label>6</label>
<addr-line>King&#x02019;s College London, Capital House, Guy&#x02019;s Campus, London, SE1 3QD, United Kingdom</addr-line>
</aff><aff id="aff007">
<label>7</label>
<addr-line>School of Nursing, Midwifery &#x00026; Social Work, University of Manchester,Oxford Rd, Manchester, M13 9PL, United Kingdom</addr-line>
</aff><aff id="aff008">
<label>8</label>
<addr-line>School of Health Sciences, Hunter Building, University Drive, University of Newcastle, Callaghn, New South Wales, 2308, Australia</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Quinn</surname><given-names>Terence J</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">
<addr-line>University of Glasgow, UNITED KINGDOM</addr-line>
</aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con" id="contrib001"><p>Conceived and designed the experiments: KH PvV CS DW AW TP SJ ST. Performed the experiments: KH TP JM MH AW. Analyzed the data: KH TP JM DW WT. Contributed reagents/materials/analysis tools: AMW MH AW SJ DW WT ST. Wrote the paper: KH TP MH AW JM SJ DW WT AMW CS PvV ST.</p></fn><corresp id="cor001">* E-mail: <email>k.hollands@salford.ac.uk</email></corresp></author-notes><pub-date pub-type="epub"><day>7</day><month>10</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>10</volume><issue>10</issue><elocation-id>e0139261</elocation-id><history><date date-type="received"><day>26</day><month>6</month><year>2015</year></date><date date-type="accepted"><day>4</day><month>9</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; 2015 Hollands et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Hollands et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="pone.0139261.pdf"/><abstract><sec id="sec001"><title>Objectives</title><p>Given the importance of vision in the control of walking and evidence indicating varied practice of walking improves mobility outcomes, this study sought to examine the feasibility and preliminary efficacy of varied walking practice in response to visual cues, for the rehabilitation of walking following stroke.</p></sec><sec id="sec002"><title>Design</title><p>This 3 arm parallel, multi-centre, assessor blind, randomised control trial was conducted within outpatient neurorehabilitation services</p></sec><sec id="sec003"><title>Participants</title><p>Community dwelling stroke survivors with walking speed &#x0003c;0.8m/s, lower limb paresis and no severe visual impairments</p></sec><sec id="sec004"><title>Intervention</title><p>Over-ground visual cue training (O-VCT), Treadmill based visual cue training (T-VCT), and Usual care (UC) delivered by physiotherapists twice weekly for 8 weeks.</p><p>Main outcome measures: Participants were randomised using computer generated random permutated balanced blocks of randomly varying size. Recruitment, retention, adherence, adverse events and mobility and balance were measured before randomisation, post-intervention and at four weeks follow-up.</p></sec><sec id="sec005"><title>Results</title><p>Fifty-six participants participated (18 T-VCT, 19 O-VCT, 19 UC). Thirty-four completed treatment and follow-up assessments. Of the participants that completed, adherence was good with 16 treatments provided over (median of) 8.4, 7.5 and 9 weeks for T-VCT, O-VCT and UC respectively. No adverse events were reported. Post-treatment improvements in walking speed, symmetry, balance and functional mobility were seen in all treatment arms.</p></sec><sec id="sec006"><title>Conclusions</title><p>Outpatient based treadmill and over-ground walking adaptability practice using visual cues are feasible and may improve mobility and balance. Future studies should continue a carefully phased approach using identified methods to improve retention.</p></sec><sec id="sec007"><title>Trial Registration</title><p>Clinicaltrials.gov <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT01600391?term=NCT01600391&#x00026;rank=1">NCT01600391</ext-link>
</p></sec></abstract><funding-group><funding-statement>This is a summary of independent research funded by the National Institute for Health Research (NIHR)&#x02019;s Research for Patient Benefit Programme (Grant Reference Number PG-PB-0609-18181). <ext-link ext-link-type="uri" xlink:href="http://www.nihr.ac.uk/funding/research-for-patient-benefit.htm">http://www.nihr.ac.uk/funding/research-for-patient-benefit.htm</ext-link>. Funding was awarded to PvV CS AW DW KH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="2"/><table-count count="5"/><page-count count="17"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec008"><title>Introduction</title><p>More than half of stroke survivors living in the community fall, often when the basic walking pattern needs to be adapted; for example when turning, stepping over or around obstacles[<xref rid="pone.0139261.ref001" ref-type="bibr">1</xref>,<xref rid="pone.0139261.ref002" ref-type="bibr">2</xref>]. This is important because, falls that occur during such manoeuvres are more likely to be injurious than those during straight walking [<xref rid="pone.0139261.ref003" ref-type="bibr">3</xref>] and this risk of injury is heightened for stroke survivors[<xref rid="pone.0139261.ref004" ref-type="bibr">4</xref>]. Although, there is strong evidence that stroke survivors have difficulties adapting their gait by turning [<xref rid="pone.0139261.ref005" ref-type="bibr">5</xref>,<xref rid="pone.0139261.ref006" ref-type="bibr">6</xref>], increasing or decreasing their stride length, shortening or narrowing steps in order to avoid obstacles[<xref rid="pone.0139261.ref007" ref-type="bibr">7</xref>&#x02013;<xref rid="pone.0139261.ref009" ref-type="bibr">9</xref>], current rehabilitation approaches for gait and mobility often focus on straight walking without practice of gait adaptability[<xref rid="pone.0139261.ref010" ref-type="bibr">10</xref>,<xref rid="pone.0139261.ref011" ref-type="bibr">11</xref>]. Further, few studies have explored the use of gait adaptability training during gait rehabilitation following stroke.</p><p>Strong evidence suggests that rehabilitation of walking following stroke should include task-specific repetitive practice [<xref rid="pone.0139261.ref011" ref-type="bibr">11</xref>&#x02013;<xref rid="pone.0139261.ref013" ref-type="bibr">13</xref>]. To improve gait adaptability, task-specific practice could include adjustment of step and stride parameters in the context of changing direction or walking over obstacles. The idea of practicing variations of a movement, such as these, to enhance motor skill acquisition, is well established [<xref rid="pone.0139261.ref014" ref-type="bibr">14</xref>&#x02013;<xref rid="pone.0139261.ref016" ref-type="bibr">16</xref>] and has been shown to improve mobility outcomes in animal models of neuroplasticity [<xref rid="pone.0139261.ref017" ref-type="bibr">17</xref>,<xref rid="pone.0139261.ref018" ref-type="bibr">18</xref>].</p><p>Evidence from studies of motor learning further indicates that learning, or re-learning, motor skills may be improved when practice is carried out in response to external cues that exploit implicitly known motor control [16[<xref rid="pone.0139261.ref019" ref-type="bibr">19</xref>]]. The use of external cues, particularly auditory cueing, within gait rehabilitation paradigms has received considerable attention and evidence supports their use to elicit normalized walking coordination patterns [<xref rid="pone.0139261.ref020" ref-type="bibr">20</xref>]. However, vision is more important than auditory cues in the control of walking when adjusting gait in response to the environment [<xref rid="pone.0139261.ref021" ref-type="bibr">21</xref>,<xref rid="pone.0139261.ref022" ref-type="bibr">22</xref>]. Further, visual cues may be more effective than auditory cues in eliciting gait adjustments in healthy adults [<xref rid="pone.0139261.ref023" ref-type="bibr">23</xref>] and to maintain dynamic stability in stroke survivors [<xref rid="pone.0139261.ref024" ref-type="bibr">24</xref>].</p><p>Thus, we hypothesize that practice of adapting gait in response to visual cues would improve walking following stroke more than usual care not incorporating visual cues. Two possible methods of practicing adaptation of walking in response to visual cues are to provide spatiotemporal cues on the ground or to project them onto a treadmill while the patient is walking. Which of these methods is most feasible or optimal is not known. Although specialist treadmills (e.g. force-instrumented with projection capabilities) have the advantage of flexible delivery of cues in both time and space in the on-going gait cycle, transfer of improvements from treadmill to overground walking may be limited [<xref rid="pone.0139261.ref010" ref-type="bibr">10</xref>]. In preparation for future efficacy trials testing the hypothesis above, the aim of this trial was to test the feasibility of 1) delivering the two methods of providing visual cues and 2) conducting a randomised controlled trial of each of these two methods versus usual care. As the purpose of feasibility trials is not to detect differences between groups, no statistical comparisons between treatments were planned in this study [<xref rid="pone.0139261.ref025" ref-type="bibr">25</xref>]. In line with guidelines for pilot and feasibility trials [<xref rid="pone.0139261.ref025" ref-type="bibr">25</xref>,<xref rid="pone.0139261.ref026" ref-type="bibr">26</xref>]he specific outcomes of this study were to: estimate likely rates of recruitment and retention of subjects, completeness of outcomes, adherence to treatment and calculate appropriate sample sizes to plan for a later trial which will investigate effectiveness [<xref rid="pone.0139261.ref025" ref-type="bibr">25</xref>,<xref rid="pone.0139261.ref026" ref-type="bibr">26</xref>].</p></sec><sec sec-type="materials|methods" id="sec009"><title>Methods</title><p>A detailed description of the trial design and the methods have been published previously [<xref rid="pone.0139261.ref027" ref-type="bibr">27</xref>] with a brief summary provided here.</p><sec id="sec010"><title>Design</title><p>This pilot, multi-centre, randomised controlled trial with three parallel groups and single-blind assessment compared Over-ground visual cue training (O-VCT), Treadmill visual cue training (T-VCT), and Usual care (UC).</p><p>Web-based randomisation was created using Stata 13.1 (StatCorp, College Station TX) statistical software with a 1:1:1 allocation using random permuted blocks of varying size prepared by the Nottingham Clinical Trials Unit (NCTU) statistician and held on a secure server. Group assignment was implemented by the outcome assessor following baseline assessment and obtaining consent. To obtain balanced groups on severity, randomisation stratified participants into two groups according to overground gait speed (Severe group: &#x0003c;0.4 m/s; Moderate group: between 0.4 m/s and 0.8 m/s [<xref rid="pone.0139261.ref028" ref-type="bibr">28</xref>]). Participants and treating therapists were aware of the intervention allocation (therapists received an unblinded email notification of allocation from the web-based randomisation). To preserve allocation concealment, the outcome assessor was kept blind to the allocation (received a blinded email confirmation of randomisation).</p></sec><sec id="sec011"><title>Participants</title><p>Community dwelling adult stroke survivors were identified, either at discharge from inpatient stroke services or at referral to community and outpatient services at six hospitals across the West-Midlands in the UK. Participants were included at any time post stroke as long as they had recovered sufficient minimum levels of mobility to take part in training. Inclusion criteria were:</p><list list-type="order"><list-item><p>had a gait impairment (speed &#x0003c;0.8m/s corresponding with limited community ambulation ability [<xref rid="pone.0139261.ref028" ref-type="bibr">28</xref>]) and residual lower limb paresis (Fugl-Meyer [<xref rid="pone.0139261.ref029" ref-type="bibr">29</xref>] lower limb score &#x0003c;34) due to their stroke (premorbid (retrospective) modified Rankin Scale [<xref rid="pone.0139261.ref030" ref-type="bibr">30</xref>] score &#x0003e;3)</p></list-item><list-item><p>were able to walk with minimal assistance (functional ambulation category [<xref rid="pone.0139261.ref031" ref-type="bibr">31</xref>] of 3 or more)</p></list-item><list-item><p>were able to follow a three-step command (as assessed by Modified Mini-mental Status Exam [<xref rid="pone.0139261.ref032" ref-type="bibr">32</xref>])</p></list-item><list-item><p>were without severe visual impairments that would prevent use of visual cue training (assessed by apple cancellation test [<xref rid="pone.0139261.ref033" ref-type="bibr">33</xref>] and ability to see overground cues),</p></list-item><list-item><p>were medically stable and</p></list-item><list-item><p>were able to give informed consent.</p></list-item></list><p>Potentially eligible participants were excluded if:</p><list list-type="order"><list-item><p>mobility limitations were attributable to non-stroke pathology</p></list-item><list-item><p>they had a co-morbidity preventing mobilization or</p></list-item><list-item><p>they required palliative care.</p></list-item></list><p>The study was approved by the National Research Ethics Committee- West Midlands (11/WM/0167) and all participants provided informed written consent. The flow of participants through the trial is depicted in <xref rid="pone.0139261.g001" ref-type="fig">Fig 1</xref>.</p><fig id="pone.0139261.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0139261.g001</object-id><label>Fig 1</label><caption><title>CONSORT study flowchart.</title><p>* Other reasons for non-completion include: complex social issues preventing participation (n = 2 TVCT, n = 2 UC), fall at home (n = 1 TVCT), new diagnosis (n = 1 TVCT), therapist decision (n = 2 OVCT), no longer eligible for rehabilitation within the NHS (n = 2 OVCT). Reasons for withdrawal of consent include: unable to attend treatment 2X/week (n = 1 TVCT, n = 1 OVCT), too fatigued after exercise (n = 1 OVCT), difficulty travelling for treatment (n = 1 TVCT), comorbid health problems (n = 1 TVCT), unknown reasons (n = 1 UC).</p></caption><graphic xlink:href="pone.0139261.g001"/></fig></sec><sec id="sec012"><title>Intervention</title><p>Treatment in UC and OVCT arms was delivered by one of 10 physiotherapists at six outpatient physiotherapy departments and T-VCT was delivered by one physiotherapist at the University of Birmingham. All three treatments were provided 1hr, 2X/week for 8 weeks. The dose was determined through consultation with clinicians (to ensure amount of treatment coincided with usual care provision and did not represent additional treatment) and patients in the trial design stages and has been employed in a previous proof-of-concept study which was sufficient to elicit significant improvements in balance and walking [<xref rid="pone.0139261.ref034" ref-type="bibr">34</xref>]. To equalize amount of walking practice a target of 20-30mins of continuous walking within a typical 1 hour appointment (with additional time allocated for warm-up, cool down and interspersion of rest as needed) was set for all treatment arms. All treating therapists received training and on-going support to deliver the treatment protocol and provided with a treatment manual. All participants continued to receive prescribed adjunct rehabilitation (such as occupational and speech and language therapies), irrespective of treatment allocation within the trial. Orthoses, walking aides and therapist assistance were all used at the clinicians&#x02019; discretion across all treatment arms. The treadmill environment of TVCT is not conducive to use walking aides so these were not used in this treatment arm.</p><sec id="sec013"><title>VCT Interventions</title><p>VCT treatment was designed to target: gait speed and symmetry, turning and adaptability of step lengths and widths. Participants assigned to VCT walked to visual cues (white rectangles, 8 cm deep &#x000d7; 40 cm wide) illuminated by an overhead projector onto a treadmill (TVCT) (CMill, Forcelink NL) or adhered to an overground walkway (OVCT). Baseline self-selected gait speed and location of cues was calculated and prescribed to treating clinicians for each patient based on individual pre-treatment gait assessment (using GaitRite). Stepping towards increasingly symmetrical step length cues was practiced, by repeated trials of stepping to cues, at increasing speed, in the first four treatment sessions. The aim was to achieve 10% incremental improvements in gait speed (monitored by clinicians with a stopwatch) while hitting symmetrically placed footfall cues. Treatment was then progressed with the same increments in gait speed to include practice of turning and stepping to cues requiring lengthening, shortening and narrowing of steps during sessions 5&#x02013;10. Practice of both these aspects of gait adaptability were then randomly interspersed in sessions 10&#x02013;16. Turning practice was achieved by asking participants to &#x02018;turn to walk between the obstacles&#x02019; in such a fashion as to &#x02018;slalom&#x02019; across the walkway/treadmill belt; making successive 90&#x000b0; turns between cues on alternate sides of the walkway a distance of 1m apart (<xref rid="pone.0139261.g002" ref-type="fig">Fig 2</xref>). In the T-VCT treatment arm, shifting illuminated cues were used to elicit step alterations at varying times in the gait cycle, and some cues would appear as obstacles to be avoided (<xref rid="pone.0139261.g002" ref-type="fig">Fig 2</xref>). Thus with the exception of obstacle avoidance and the ability to practice changes to walking in time-critical manner in the T-VCT, the step alterations were standardised across both VCT treatment arms.</p><fig id="pone.0139261.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0139261.g002</object-id><label>Fig 2</label><caption><title>Illustration of training target placement for O-VCT (a) symmetry, (b) adaptability, (c) &#x00026; turning and T-VCT (d) symmetry, (e) adaptability &#x00026; (f) turning.</title></caption><graphic xlink:href="pone.0139261.g002"/></fig></sec><sec id="sec014"><title>Control Intervention</title><p>UC was standard physiotherapy currently provided to stroke patients in the NHS; broadly defined as task-specific-practice of walking and/or components of gait (e.g. weight shifting or initiation); exercises for strength balance and coordination; and/or prescription of assistive devices. The use of visual cues for foot placement, practicing symmetry or timing of gait, or walking to, or avoiding targets was excluded. Treatment content of UC was recorded in treatment logs by ticking relevant categories for environment, aids and equipment used, activities undertaken, facilitation and feedback provided, and duration of each treatment session</p></sec></sec><sec id="sec015"><title>Assessments and outcome measures</title><p>Measures of feasibility were recorded throughout the 18 month active recruitment (June 2012-October 2013) and follow-up periods (October 2013- January 2014) and included; recruitment rates (i.e. number of potentially eligible participants who agree or decline consent), retention, adherence (i.e. number of sessions attended and time spent actively practicing walking using treatment logs completed by the treating physiotherapists), completeness of outcome measures (% missing data) and adverse events.</p><p>Demographic information including stroke date and lesion location, age, co-morbidities, communication skills (Sheffield aphasia screening test [<xref rid="pone.0139261.ref035" ref-type="bibr">35</xref>]), cognitive competence (MMSE [<xref rid="pone.0139261.ref032" ref-type="bibr">32</xref>]), pre-morbid disability (modified Rankin Scale [<xref rid="pone.0139261.ref030" ref-type="bibr">30</xref>]), and visual attention (Apple Cancellation Test [<xref rid="pone.0139261.ref033" ref-type="bibr">33</xref>]) was recorded at baseline to describe patient characteristics.</p><p>Measures of potential efficacy were measured, before randomisation (baseline), post-intervention (at 8 weeks) and at follow-up (4 weeks post intervention). The primary outcome was walking speed. Secondary outcomes were spatial and temporal symmetry of gait (measured by GaitRite) [<xref rid="pone.0139261.ref036" ref-type="bibr">36</xref>]); time to turn 180&#x000b0;; adaptability of gait (success rate in target stepping); lower limb impairments (Fugl-Meyer lower limb motor assessment [<xref rid="pone.0139261.ref029" ref-type="bibr">29</xref>]); falls risk (Falls Efficacy Scale [<xref rid="pone.0139261.ref037" ref-type="bibr">37</xref>]) quality of life (SF&#x02013;12) [<xref rid="pone.0139261.ref038" ref-type="bibr">38</xref>,<xref rid="pone.0139261.ref039" ref-type="bibr">39</xref>]; and mobility (Functional Ambulation Category [<xref rid="pone.0139261.ref031" ref-type="bibr">31</xref>]; Timed Up and Go [<xref rid="pone.0139261.ref040" ref-type="bibr">40</xref>]).</p></sec><sec id="sec016"><title>Sample size and analysis</title><p>We aimed to recruit and randomise 60 participants (n = 20 per arm) to gain sufficient data to estimate the standard deviation of outcome measures for planning a subsequent definitive trial. Descriptive analyses established recruitment, adherence and retention rates and completeness and variability of outcome measures.</p></sec></sec><sec sec-type="results" id="sec017"><title>Results</title><p>Overall 60 patients provided informed consent and 56 were randomized (<xref rid="pone.0139261.g001" ref-type="fig">Fig 1</xref>). The mean recruitment rate was one patient per month per site.</p><p>Demographic information can be found in <xref rid="pone.0139261.t001" ref-type="table">Table 1</xref>
</p><table-wrap id="pone.0139261.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0139261.t001</object-id><label>Table 1</label><caption><title>Demographic and clinical characteristics.</title><p>All data are N (%)&#x02019;s unless specified.</p></caption><alternatives><graphic id="pone.0139261.t001g" xlink:href="pone.0139261.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th rowspan="2" align="left" colspan="1">Baseline characteristic</th><th colspan="3" align="center" rowspan="1">Treatment arm</th></tr><tr><th align="left" rowspan="1" colspan="1">Treadmill VCT (N = 18)</th><th align="left" rowspan="1" colspan="1">Over-ground VCT (N = 19)</th><th align="left" rowspan="1" colspan="1">Usual care (N = 19)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<bold>Age at inclusion (years)</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Mean [SD]</td><td align="left" rowspan="1" colspan="1">59.0[18.0]</td><td align="left" rowspan="1" colspan="1">56.1[12.2]</td><td align="left" rowspan="1" colspan="1">60.0[13.6]</td></tr><tr><td align="left" rowspan="1" colspan="1">Median[IQR]</td><td align="left" rowspan="1" colspan="1">59.2[49.6,72.6]</td><td align="left" rowspan="1" colspan="1">55.8[47.6,64.8]</td><td align="left" rowspan="1" colspan="1">62.2[48,67.7]</td></tr><tr><td align="left" rowspan="1" colspan="1">[range]</td><td align="left" rowspan="1" colspan="1">[18.7,87.4]</td><td align="left" rowspan="1" colspan="1">[37.1,80.6]</td><td align="left" rowspan="1" colspan="1">[36.5,85.9]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Gender</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Males</td><td align="left" rowspan="1" colspan="1">11(61%)</td><td align="left" rowspan="1" colspan="1">14(74%)</td><td align="left" rowspan="1" colspan="1">8(42%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Females</td><td align="left" rowspan="1" colspan="1">7(39%)</td><td align="left" rowspan="1" colspan="1">5(26%)</td><td align="left" rowspan="1" colspan="1">11(58%)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Side of Stoke</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">7(39%)</td><td align="left" rowspan="1" colspan="1">8(42%)</td><td align="left" rowspan="1" colspan="1">6(32%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">10(56%)</td><td align="left" rowspan="1" colspan="1">10(53%)</td><td align="left" rowspan="1" colspan="1">10(52%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Bilateral</td><td align="left" rowspan="1" colspan="1">1(5%)</td><td align="left" rowspan="1" colspan="1">1(5%)</td><td align="left" rowspan="1" colspan="1">3(16%)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Time since stroke (months)</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Mean (SD)</td><td align="left" rowspan="1" colspan="1">7.8[15.4]</td><td align="left" rowspan="1" colspan="1">8.6[11.3]</td><td align="left" rowspan="1" colspan="1">7.9[11.1]</td></tr><tr><td align="left" rowspan="1" colspan="1">Median[IQR]</td><td align="left" rowspan="1" colspan="1">3.7[1.5,8.5]</td><td align="left" rowspan="1" colspan="1">7.1[1.8,10.9]</td><td align="left" rowspan="1" colspan="1">4.2[1.8,8.5]</td></tr><tr><td align="left" rowspan="1" colspan="1">[range]</td><td align="left" rowspan="1" colspan="1">[0.5,67.9]</td><td align="left" rowspan="1" colspan="1">[0.6,52.1]</td><td align="left" rowspan="1" colspan="1">[0.3,42.6]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Stroke Type</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Ischemic</td><td align="left" rowspan="1" colspan="1">15(83%)</td><td align="left" rowspan="1" colspan="1">17(90%)</td><td align="left" rowspan="1" colspan="1">17(90%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Intracerebral haemorrhage</td><td align="left" rowspan="1" colspan="1">3(17%)</td><td align="left" rowspan="1" colspan="1">2(10%)</td><td align="left" rowspan="1" colspan="1">2(10%)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Apple cancellation test</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Pass</td><td align="left" rowspan="1" colspan="1">15(83%)</td><td align="left" rowspan="1" colspan="1">14(74%)</td><td align="left" rowspan="1" colspan="1">13(68%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Fail</td><td align="left" rowspan="1" colspan="1">3(17%)</td><td align="left" rowspan="1" colspan="1">5(26%)</td><td align="left" rowspan="1" colspan="1">6(32%)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Sheffield screening test</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Expressive skills score</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Mean [SD]</td><td align="left" rowspan="1" colspan="1">9.0[4.1]</td><td align="left" rowspan="1" colspan="1">8.9[4.1]</td><td align="left" rowspan="1" colspan="1">10.7[0.9]</td></tr><tr><td align="left" rowspan="1" colspan="1">Median[IQR]</td><td align="left" rowspan="1" colspan="1">11[0,11]</td><td align="left" rowspan="1" colspan="1">11[0,11]</td><td align="left" rowspan="1" colspan="1">11[7,11]</td></tr><tr><td align="left" rowspan="1" colspan="1">[range]</td><td align="left" rowspan="1" colspan="1">[0,11]</td><td align="left" rowspan="1" colspan="1">[0,11]</td><td align="left" rowspan="1" colspan="1">[7,11]</td></tr><tr><td align="left" rowspan="1" colspan="1">Receptive and expressive skills score</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Mean [SD]</td><td align="left" rowspan="1" colspan="1">16.7[6.0]</td><td align="left" rowspan="1" colspan="1">16.8[5.2]</td><td align="left" rowspan="1" colspan="1">19.0[1.3]</td></tr><tr><td align="left" rowspan="1" colspan="1">Median[IQR]</td><td align="left" rowspan="1" colspan="1">19[14,20]</td><td align="left" rowspan="1" colspan="1">19[4,20]</td><td align="left" rowspan="1" colspan="1">19.5[3,20]</td></tr><tr><td align="left" rowspan="1" colspan="1">[range]</td><td align="left" rowspan="1" colspan="1">[3,20]</td><td align="left" rowspan="1" colspan="1">[4,20]</td><td align="left" rowspan="1" colspan="1">[14,20]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Mini Mental State Examination total score</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Mean [SD]</td><td align="left" rowspan="1" colspan="1">24.9[5.6]</td><td align="left" rowspan="1" colspan="1">24.5[6.3]</td><td align="left" rowspan="1" colspan="1">26.3[3.0]</td></tr><tr><td align="left" rowspan="1" colspan="1">Median[IQR]</td><td align="left" rowspan="1" colspan="1">27[12,30]</td><td align="left" rowspan="1" colspan="1">26[11,30]</td><td align="left" rowspan="1" colspan="1">27[20,30]</td></tr><tr><td align="left" rowspan="1" colspan="1">[range]</td><td align="left" rowspan="1" colspan="1">[12,30]</td><td align="left" rowspan="1" colspan="1">[11,30]</td><td align="left" rowspan="1" colspan="1">[20,30]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Gait speed (m/s)</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Mean [SD]</td><td align="left" rowspan="1" colspan="1">0.41[0.22]</td><td align="left" rowspan="1" colspan="1">0.40[0.21]</td><td align="left" rowspan="1" colspan="1">0.37[0.21]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Berg Balance Scale</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Mean [SD]</td><td align="left" rowspan="1" colspan="1">41.6[8]</td><td align="left" rowspan="1" colspan="1">42.1[9.8]</td><td align="left" rowspan="1" colspan="1">42.6[7.6]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Fugl-Meyer Lower Limb</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Mean [SD]</td><td align="left" rowspan="1" colspan="1">22.3[5.7]</td><td align="left" rowspan="1" colspan="1">22.5[4.9]</td><td align="left" rowspan="1" colspan="1">23.9[6.2]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Modified Rankin Scale</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">No symptoms (score 0)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Some symptoms (score 1)</td><td align="left" rowspan="1" colspan="1">3(17%)</td><td align="left" rowspan="1" colspan="1">2(10%)</td><td align="left" rowspan="1" colspan="1">3(16%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Slight disability (score 2)</td><td align="left" rowspan="1" colspan="1">5(28%)</td><td align="left" rowspan="1" colspan="1">4(21%)</td><td align="left" rowspan="1" colspan="1">7(37%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Moderate disability (score 3)</td><td align="left" rowspan="1" colspan="1">7(39%)</td><td align="left" rowspan="1" colspan="1">12(63%)</td><td align="left" rowspan="1" colspan="1">7(37%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Moderately severe disabilities (score 4)</td><td align="left" rowspan="1" colspan="1">2(11%)</td><td align="left" rowspan="1" colspan="1">1(5%)</td><td align="left" rowspan="1" colspan="1">2(10%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Severe disabilities (score 5)</td><td align="left" rowspan="1" colspan="1">1(5%)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Medical history<xref rid="t001fn001" ref-type="table-fn">^</xref></bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Cardiovascular disease</td><td align="left" rowspan="1" colspan="1">5(28%)</td><td align="left" rowspan="1" colspan="1">8(42%)</td><td align="left" rowspan="1" colspan="1">5(26%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Hepatic disease</td><td align="left" rowspan="1" colspan="1">1(6%)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Renal disease</td><td align="left" rowspan="1" colspan="1">1(6%)</td><td align="left" rowspan="1" colspan="1">1(5%)</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Neurological disease</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">History of falls</td><td align="left" rowspan="1" colspan="1">1(6%)</td><td align="left" rowspan="1" colspan="1">2(10%)</td><td align="left" rowspan="1" colspan="1">3(16%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Respiratory disease</td><td align="left" rowspan="1" colspan="1">1(6%)</td><td align="left" rowspan="1" colspan="1">3(16%)</td><td align="left" rowspan="1" colspan="1">2(10%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Gastrointestinal disease</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">3(16%)</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Urological conditions</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1(5%)</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Musculoskeletal problems</td><td align="left" rowspan="1" colspan="1">3(17%)</td><td align="left" rowspan="1" colspan="1">3(16%)</td><td align="left" rowspan="1" colspan="1">3(16%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Dermatological</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Other</td><td align="left" rowspan="1" colspan="1">11(61%)</td><td align="left" rowspan="1" colspan="1">15(79%)</td><td align="left" rowspan="1" colspan="1">13(68%)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Number of participants without co-morbidities</bold>
</td><td align="left" rowspan="1" colspan="1">5(28%)</td><td align="left" rowspan="1" colspan="1">3(16%)</td><td align="left" rowspan="1" colspan="1">4(21%)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Number of participants with 1 co-comorbidity</bold>
</td><td align="left" rowspan="1" colspan="1">8(44%)</td><td align="left" rowspan="1" colspan="1">4(21%)</td><td align="left" rowspan="1" colspan="1">7(37%)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Number of participants with more than 1 co-morbidity</bold>
</td><td align="left" rowspan="1" colspan="1">5(28%)</td><td align="left" rowspan="1" colspan="1">12(63%)</td><td align="left" rowspan="1" colspan="1">8(42%)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>^data are not mutually exclusive</p></fn></table-wrap-foot></table-wrap><p>Twenty-two participants did not complete; 7 from TVCT, 9 from OVCT and 6 from UC. Reasons for non-completion are provided in <xref rid="pone.0139261.g001" ref-type="fig">Fig 1</xref>. Participants who completed the intervention and assessments tended to be older, longer post-stroke and walked more slowly than those who withdrew (<xref rid="pone.0139261.t002" ref-type="table">Table 2</xref>).</p><table-wrap id="pone.0139261.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0139261.t002</object-id><label>Table 2</label><caption><title>Demographic and clinical characteristics by study completion status.</title><p>All data are N (%)&#x02019;s unless specified.</p></caption><alternatives><graphic id="pone.0139261.t002g" xlink:href="pone.0139261.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th rowspan="2" align="left" colspan="1">Baseline characteristic</th><th colspan="2" align="center" rowspan="1">Completion of study<xref rid="t002fn002" ref-type="table-fn">*</xref>
</th></tr><tr><th align="left" rowspan="1" colspan="1">Non-completers (N = 22)</th><th align="left" rowspan="1" colspan="1">Completers (N = 34)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<bold>Age at inclusion (years)</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Mean [SD]</td><td align="left" rowspan="1" colspan="1">55.8[16.6]</td><td align="left" rowspan="1" colspan="1">60.0[13.1]</td></tr><tr><td align="left" rowspan="1" colspan="1">Median[IQR]</td><td align="left" rowspan="1" colspan="1">53.7[48.0,66.5]</td><td align="left" rowspan="1" colspan="1">62.6[49.7,69.0]</td></tr><tr><td align="left" rowspan="1" colspan="1">[range]</td><td align="left" rowspan="1" colspan="1">[18.7,87.4]</td><td align="left" rowspan="1" colspan="1">[32.3,85.9]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Gender</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">12(54%)</td><td align="left" rowspan="1" colspan="1">21(62%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">10(46%)</td><td align="left" rowspan="1" colspan="1">13(38%)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Side of Stoke</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">10(45%)</td><td align="left" rowspan="1" colspan="1">11(32%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">11(50%)</td><td align="left" rowspan="1" colspan="1">19(56%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Bilateral</td><td align="left" rowspan="1" colspan="1">1(5%)</td><td align="left" rowspan="1" colspan="1">4(12%)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Time since stroke (months)</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Mean (SD)</td><td align="left" rowspan="1" colspan="1">6.1[10.8]</td><td align="left" rowspan="1" colspan="1">9.4[13.4]</td></tr><tr><td align="left" rowspan="1" colspan="1">Median[IQR]</td><td align="left" rowspan="1" colspan="1">3.0[1.3,7.3]</td><td align="left" rowspan="1" colspan="1">4.7[2.7,10.3]</td></tr><tr><td align="left" rowspan="1" colspan="1">[range]</td><td align="left" rowspan="1" colspan="1">[0.3,52.1]</td><td align="left" rowspan="1" colspan="1">[0.6,67.9]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Stroke Type</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Ischemic</td><td align="left" rowspan="1" colspan="1">20(91%)</td><td align="left" rowspan="1" colspan="1">29(85%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Intracerebral haemorrhage</td><td align="left" rowspan="1" colspan="1">2(9%)</td><td align="left" rowspan="1" colspan="1">5(15%)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Apple cancellation test</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Pass</td><td align="left" rowspan="1" colspan="1">17(77%)</td><td align="left" rowspan="1" colspan="1">25(74%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Fail</td><td align="left" rowspan="1" colspan="1">5(23%)</td><td align="left" rowspan="1" colspan="1">9(26%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Sheffield screening test</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Expressive skills score</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Mean [SD]</td><td align="left" rowspan="1" colspan="1">8.6[4.3]</td><td align="left" rowspan="1" colspan="1">10.2[2.6]</td></tr><tr><td align="left" rowspan="1" colspan="1">Median[IQR]</td><td align="left" rowspan="1" colspan="1">11[8,11]</td><td align="left" rowspan="1" colspan="1">11[11,11]</td></tr><tr><td align="left" rowspan="1" colspan="1">[range]</td><td align="left" rowspan="1" colspan="1">[0,11]</td><td align="left" rowspan="1" colspan="1">[0,11]</td></tr><tr><td align="left" rowspan="1" colspan="1">Receptive and expressive skills score</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Mean [SD]</td><td align="left" rowspan="1" colspan="1">16.2[5.9]</td><td align="left" rowspan="1" colspan="1">18.4[3.5]</td></tr><tr><td align="left" rowspan="1" colspan="1">Median[IQR]</td><td align="left" rowspan="1" colspan="1">19[15,20]</td><td align="left" rowspan="1" colspan="1">19[19,20]</td></tr><tr><td align="left" rowspan="1" colspan="1">[range]</td><td align="left" rowspan="1" colspan="1">[3,20]</td><td align="left" rowspan="1" colspan="1">[5,20]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Mini Mental State Examination total score</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Mean [SD]</td><td align="left" rowspan="1" colspan="1">23.8[6.1]</td><td align="left" rowspan="1" colspan="1">26.1[4.3]</td></tr><tr><td align="left" rowspan="1" colspan="1">Median[IQR]</td><td align="left" rowspan="1" colspan="1">26[21,28]</td><td align="left" rowspan="1" colspan="1">27.5[25,30]</td></tr><tr><td align="left" rowspan="1" colspan="1">[range]</td><td align="left" rowspan="1" colspan="1">[11,30]</td><td align="left" rowspan="1" colspan="1">[16,30]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Gait speed (m/s)</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Mean [SD]</td><td align="left" rowspan="1" colspan="1">0.44 [0.23]</td><td align="left" rowspan="1" colspan="1">0.37 [0.19]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Berg Balance Scale</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Mean [SD]</td><td align="left" rowspan="1" colspan="1">41.6 [8]</td><td align="left" rowspan="1" colspan="1">42.1 [7.6]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Fugl-Meyer Lower Limb</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Mean [SD]</td><td align="left" rowspan="1" colspan="1">22.3 [5.7]</td><td align="left" rowspan="1" colspan="1">22.8 [5.8]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Pre-morbid Modified Rankin Scale</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">No symptoms (score 0)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Some symptoms (score 1)</td><td align="left" rowspan="1" colspan="1">2(9%)</td><td align="left" rowspan="1" colspan="1">6(18%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Slight disability (score 2)</td><td align="left" rowspan="1" colspan="1">7(32%)</td><td align="left" rowspan="1" colspan="1">9(26%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Moderate disability (score 3)</td><td align="left" rowspan="1" colspan="1">11(50%)</td><td align="left" rowspan="1" colspan="1">15(44%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Moderately severe disabilities (score 4)</td><td align="left" rowspan="1" colspan="1">2(9%)</td><td align="left" rowspan="1" colspan="1">3(9%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Severe disabilities (score 5)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1(3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Medical history<xref rid="t002fn001" ref-type="table-fn">^</xref></bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Cardiovascular disease</td><td align="left" rowspan="1" colspan="1">7(32%)</td><td align="left" rowspan="1" colspan="1">11(32%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Hepatic disease</td><td align="left" rowspan="1" colspan="1">1(5%)</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Renal disease</td><td align="left" rowspan="1" colspan="1">1(5%)</td><td align="left" rowspan="1" colspan="1">1(3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Neurological disease</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">History of falls</td><td align="left" rowspan="1" colspan="1">3(14%)</td><td align="left" rowspan="1" colspan="1">3(9%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Respiratory disease</td><td align="left" rowspan="1" colspan="1">2(9%)</td><td align="left" rowspan="1" colspan="1">4(12%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Gastrointestinal disease</td><td align="left" rowspan="1" colspan="1">1(5%)</td><td align="left" rowspan="1" colspan="1">2(6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Urological conditions</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1(3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Musculoskeletal problems</td><td align="left" rowspan="1" colspan="1">4(18%)</td><td align="left" rowspan="1" colspan="1">5(15%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Dermatological</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Other</td><td align="left" rowspan="1" colspan="1">15(68%)</td><td align="left" rowspan="1" colspan="1">24(71%)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Number of participants without co-morbidities</bold>
</td><td align="left" rowspan="1" colspan="1">5(23%)</td><td align="left" rowspan="1" colspan="1">7(21%)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Number of participants with 1 co-comorbidity</bold>
</td><td align="left" rowspan="1" colspan="1">8(36%)</td><td align="left" rowspan="1" colspan="1">11(32%)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Number of participants with more than 1 co-morbidity</bold>
</td><td align="left" rowspan="1" colspan="1">9(41%)</td><td align="left" rowspan="1" colspan="1">16(47%)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>^data are not mutually exclusive</p></fn><fn id="t002fn002"><p>*completion of study means data collected at 12 weeks follow up</p></fn></table-wrap-foot></table-wrap><p>VCT treatments in the participants who completed were delivered closely to the target &#x02018;dose&#x02019; of therapy. The median time to deliver 16 sessions of treatment is detailed in <xref rid="pone.0139261.t003" ref-type="table">Table 3</xref>. Appointment duration was more often recorded in the treatment logs rather than actual duration of walking practice within treatment sessions for OVCT and UC. No adverse events were reported. One participant in each of TVCT and OVCT reported stumbling/near falls requiring steadying by the physiotherapist or the safety harness in TVCT. These non-injurious events were reported to the Trial Steering Committee.</p><table-wrap id="pone.0139261.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0139261.t003</object-id><label>Table 3</label><caption><title>Adherence to treatment.</title></caption><alternatives><graphic id="pone.0139261.t003g" xlink:href="pone.0139261.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th rowspan="2" align="left" colspan="1">Compliance</th><th colspan="3" align="center" rowspan="1">Treatment</th></tr><tr><th align="left" rowspan="1" colspan="1">Treadmill VCT</th><th align="left" rowspan="1" colspan="1">Over-ground VCT</th><th align="left" rowspan="1" colspan="1">Usual care</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<bold>Number of participants with data</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>14</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>12</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>11</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Number of sessions</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">N (%) attended 14&#x02013;16 sessions</td><td align="left" rowspan="1" colspan="1">10(71%)</td><td align="left" rowspan="1" colspan="1">7(58%)</td><td align="left" rowspan="1" colspan="1">5(45%)</td></tr><tr><td align="left" rowspan="1" colspan="1">N (%) attended &#x0003c;14 sessions</td><td align="left" rowspan="1" colspan="1">4(29%)</td><td align="left" rowspan="1" colspan="1">5(42%)</td><td align="left" rowspan="1" colspan="1">6(55%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Median (IQR) sessions attended by week 12</td><td align="left" rowspan="1" colspan="1">14[14,16]</td><td align="left" rowspan="1" colspan="1">14.5[8,16]</td><td align="left" rowspan="1" colspan="1">12[2,16]</td></tr><tr><td align="left" rowspan="1" colspan="1">Median (IQR) weeks taken to attend full sessions</td><td align="left" rowspan="1" colspan="1">8.4[0.6,15.7]</td><td align="left" rowspan="1" colspan="1">7.5[0.4,12.6]</td><td align="left" rowspan="1" colspan="1">9.1[0.1,12.7]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Number of minutes of walking practice within session</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<underline><bold>Phase I</bold></underline>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Median (IQR) of minutes per session completed</td><td align="left" rowspan="1" colspan="1">38[30,50]</td><td align="left" rowspan="1" colspan="1">55[43,60]</td><td align="left" rowspan="1" colspan="1">60[50,60]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<underline><bold>Phase II</bold></underline>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Median (IQR) of minutes per session completed</td><td align="left" rowspan="1" colspan="1">43[34,53]</td><td align="left" rowspan="1" colspan="1">55[42,69]</td><td align="left" rowspan="1" colspan="1">60[50,60]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<underline><bold>Phase III</bold></underline>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Median (IQR) of minutes per session completed</td><td align="left" rowspan="1" colspan="1">43[35,53]</td><td align="left" rowspan="1" colspan="1">58[52,59]</td><td align="left" rowspan="1" colspan="1">60[60,60]</td></tr></tbody></table></alternatives></table-wrap><p>All outcome measures for the participants who remained in the study until the end were complete for all sites, treatment arms and assessment time points.</p><p>
<xref rid="pone.0139261.t004" ref-type="table">Table 4</xref> shows mean changes from baseline primary outcomes. Improvements in gait speed were seen following treatment in all treatment arms. Symmetry of step length (which may reflect paretic leg propulsive force generation [<xref rid="pone.0139261.ref041" ref-type="bibr">41</xref>]) and single support time (related to balance control and ability to turn [<xref rid="pone.0139261.ref042" ref-type="bibr">42</xref>,<xref rid="pone.0139261.ref043" ref-type="bibr">43</xref>]) showed mean changes in the direction of improvement immediately following OVCT and TVCT treatment and by follow-up in UC. Time to turn 180&#x000b0; decreased in both OVCT and UC treatment arms, with greatest improvements in the direction of the non-paretic lower limb. TVCT did not yield reductions in time to turn.</p><table-wrap id="pone.0139261.t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0139261.t004</object-id><label>Table 4</label><caption><title>Change from baseline to post-treatment (8 weeks) and baseline to follow-up (12 weeks) for outcomes of speed, symmetry (step length and single support duration), and time to turn 180 degrees.</title><p>For all measures apart from time to turn and symmetry ratios positive values indicate improvement. For time to turn negative values indicate reduced time to turn and improvement. Symmetry ratios are calculated by dividing the larger of the paretic or non-paretic value (step length or single support time) by the smaller (in accordance with recommendations (Patterson et al, 2010)). Thus a value of 1 represents symmetrical gait and &#x0003e;1 is increasingly asymmetrical. Mean changes with negative values therefore indicate improvements towards a more symmetrical gait.</p></caption><alternatives><graphic id="pone.0139261.t004g" xlink:href="pone.0139261.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th rowspan="2" align="left" colspan="1">Change from Baseline Assessment</th><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Treadmill VCT</th><th align="left" rowspan="1" colspan="1">Over-ground VCT</th><th align="left" rowspan="1" colspan="1">Usual care</th></tr><tr><th align="left" rowspan="1" colspan="1">Outcome measure</th><th align="left" rowspan="1" colspan="1">
<italic>Median [IQR]</italic>
</th><th align="left" rowspan="1" colspan="1">
<italic>Median [IQR]</italic>
</th><th align="left" rowspan="1" colspan="1">
<italic>Median [IQR]</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<bold>Post-treatment</bold>
</td><td align="left" rowspan="1" colspan="1">Gait speed(m/s)</td><td align="left" rowspan="1" colspan="1">
<italic>0</italic>.<italic>14[0</italic>.<italic>06</italic>,<italic>0</italic>.<italic>32]</italic>
</td><td align="left" rowspan="1" colspan="1">
<italic>0</italic>.<italic>18[0</italic>.<italic>05</italic>,<italic>0</italic>.<italic>34]</italic>
</td><td align="left" rowspan="1" colspan="1">
<italic>0</italic>.<italic>09[0</italic>, <italic>0</italic>.<italic>15]</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Symmetry ratio: Step length(cm)</td><td align="left" rowspan="1" colspan="1">
<italic>-0</italic>.<italic>1[-0</italic>.<italic>3</italic>,<italic>0]</italic>
</td><td align="left" rowspan="1" colspan="1">
<italic>-0</italic>.<italic>1[-0</italic>.<italic>6</italic>,<italic>0</italic>.<italic>2]</italic>
</td><td align="left" rowspan="1" colspan="1">
<italic>-0</italic>.<italic>1[-0</italic>.<italic>5</italic>,<italic>0</italic>.<italic>2]</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Symmetry ratio: Single support duration(s)</td><td align="left" rowspan="1" colspan="1">
<italic>-0</italic>.<italic>4[-0</italic>.<italic>7</italic>,<italic>-0</italic>.<italic>2]</italic>
</td><td align="left" rowspan="1" colspan="1">
<italic>-0</italic>.<italic>4[-0</italic>.<italic>9</italic>,<italic>0</italic>.<italic>2]</italic>
</td><td align="left" rowspan="1" colspan="1">
<italic>0[-0</italic>.<italic>2</italic>,<italic>0</italic>.<italic>2]</italic>
</td></tr><tr><td rowspan="2" align="left" colspan="1"/><td align="left" rowspan="1" colspan="1">Time to turn 180&#x000b0; (s) <italic>Paretic side</italic>
</td><td align="left" rowspan="1" colspan="1">
<italic>0</italic>.<italic>2[-0</italic>.<italic>7</italic>,<italic>1]</italic>
</td><td align="left" rowspan="1" colspan="1">
<italic>-0</italic>.<italic>6[-1</italic>.<italic>8</italic>,<italic>0</italic>.<italic>6]</italic>
</td><td align="left" rowspan="1" colspan="1">
<italic>0</italic>.<italic>4[-1</italic>.<italic>1</italic>,<italic>1</italic>.<italic>2]</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>Non-paretic side</italic>
</td><td align="left" rowspan="1" colspan="1">
<italic>0</italic>.<italic>3[-1</italic>,<italic>1</italic>.<italic>2]</italic>
</td><td align="left" rowspan="1" colspan="1">
<italic>-0</italic>.<italic>8[-2</italic>.<italic>2</italic>,<italic>-0</italic>.<italic>2]</italic>
</td><td align="left" rowspan="1" colspan="1">
<italic>-0</italic>.<italic>9[-1</italic>.<italic>4</italic>,<italic>0</italic>.<italic>8]</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Follow-up</bold>
</td><td align="left" rowspan="1" colspan="1">Gait speed(m/s)</td><td align="left" rowspan="1" colspan="1">
<italic>0</italic>.<italic>12[0</italic>.<italic>01</italic>,<italic>0</italic>.<italic>26]</italic>
</td><td align="left" rowspan="1" colspan="1">
<italic>0</italic>.<italic>18[0</italic>.<italic>06</italic>,<italic>0</italic>.<italic>45]</italic>
</td><td align="left" rowspan="1" colspan="1">
<italic>0</italic>.<italic>20[0</italic>.<italic>03</italic>,<italic>0</italic>.<italic>28]</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Symmetry ratio: Step length(cm)</td><td align="left" rowspan="1" colspan="1">
<italic>0[-0</italic>.<italic>3</italic>,<italic>0]</italic>
</td><td align="left" rowspan="1" colspan="1">
<italic>-0</italic>.<italic>1[-0</italic>.<italic>9</italic>,<italic>0</italic>.<italic>1]</italic>
</td><td align="left" rowspan="1" colspan="1">
<italic>-0</italic>.<italic>1[-0</italic>.<italic>3</italic>,<italic>0</italic>.<italic>1]</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Symmetry ratio: Single support duration(s)</td><td align="left" rowspan="1" colspan="1">
<italic>-0</italic>.<italic>2[-1</italic>,<italic>0</italic>.<italic>3]</italic>
</td><td align="left" rowspan="1" colspan="1">
<italic>-0</italic>.<italic>6[-1</italic>.<italic>7</italic>,<italic>0]</italic>
</td><td align="left" rowspan="1" colspan="1">
<italic>-0</italic>.<italic>1[-0</italic>.<italic>3</italic>,<italic>0</italic>.<italic>2]</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Time to turn 180&#x000b0; (s) <italic>Paretic side</italic>
</td><td align="left" rowspan="1" colspan="1">
<italic>0</italic>.<italic>1[-1</italic>.<italic>4</italic>,<italic>3</italic>.<italic>7]</italic>
</td><td align="left" rowspan="1" colspan="1">
<italic>0</italic>.<italic>2[-1</italic>.<italic>6</italic>,<italic>0</italic>.<italic>9]</italic>
</td><td align="left" rowspan="1" colspan="1">
<italic>-0</italic>.<italic>8[-1</italic>.<italic>8</italic>,<italic>0</italic>.<italic>4]</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<italic>Non-paretic side</italic>
</td><td align="left" rowspan="1" colspan="1">
<italic>-0</italic>.<italic>1[-1</italic>.<italic>3</italic>,<italic>2</italic>.<italic>3]</italic>
</td><td align="left" rowspan="1" colspan="1">
<italic>-0</italic>.<italic>7[-1</italic>.<italic>1</italic>,<italic>0</italic>.<italic>8]</italic>
</td><td align="left" rowspan="1" colspan="1">
<italic>-1</italic>.<italic>8[-3</italic>.<italic>7</italic>,<italic>0</italic>.<italic>3]</italic>
</td></tr></tbody></table></alternatives></table-wrap><p>
<xref rid="pone.0139261.t005" ref-type="table">Table 5</xref> presents data for secondary outcomes. Improvements across all three treatment arms were seen in BBS and TUG. However, scores on the FM Lower limb scale and the FES did not change appreciably in any of the treatment arms. FAC scores indicate a greater proportion of participants became independent when walking on non-level surfaces following OVCT(n = 8)66% than either TVCT (n = 3) 46% or UC(n = 6) 25%.</p><table-wrap id="pone.0139261.t005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0139261.t005</object-id><label>Table 5</label><caption><title>Secondary outcomes summary.</title></caption><alternatives><graphic id="pone.0139261.t005g" xlink:href="pone.0139261.t005"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Treadmill VCT</th><th align="center" rowspan="1" colspan="1">Over-ground VCT</th><th align="center" rowspan="1" colspan="1">Usual care</th></tr><tr><th align="center" rowspan="1" colspan="1">Secondary outcome</th><th align="center" rowspan="1" colspan="1">Assessment Time point</th><th align="center" rowspan="1" colspan="1">
<italic>Median [IQR]</italic>
</th><th align="center" rowspan="1" colspan="1">
<italic>Median [IQR]</italic>
</th><th align="center" rowspan="1" colspan="1">
<italic>Median [IQR]</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<bold>TUG (seconds)</bold>
</td><td align="center" rowspan="1" colspan="1">Baseline</td><td align="center" rowspan="1" colspan="1">
<italic>46</italic>.<italic>8[30</italic>.<italic>8</italic>,<italic>70</italic>.<italic>6]</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>35</italic>.<italic>6[20</italic>.<italic>9</italic>,<italic>54]</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>39</italic>.<italic>9[28</italic>.<italic>5</italic>,<italic>71</italic>.<italic>4]</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Post-treatment</td><td align="center" rowspan="1" colspan="1">
<italic>29</italic>.<italic>7[20</italic>.<italic>7</italic>,<italic>50</italic>.<italic>2]</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>34</italic>.<italic>4[17</italic>.<italic>3</italic>,<italic>55</italic>.<italic>4]</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>31</italic>.<italic>2[21</italic>.<italic>4</italic>,<italic>55</italic>.<italic>2]</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Follow-up</td><td align="center" rowspan="1" colspan="1">
<italic>28</italic>.<italic>3[18</italic>.<italic>9</italic>,<italic>59</italic>.<italic>7]</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>35</italic>.<italic>2[15</italic>.<italic>5</italic>,<italic>45]</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>26</italic>.<italic>8[21</italic>.<italic>9</italic>,<italic>38</italic>.<italic>7]</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Berg-Balance Scale</bold>
</td><td align="center" rowspan="1" colspan="1">Baseline</td><td align="center" rowspan="1" colspan="1">
<italic>43</italic>.<italic>5[37</italic>,<italic>48]</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>42[34</italic>,<italic>52]</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>42[37</italic>,<italic>47]</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Post-treatment</td><td align="center" rowspan="1" colspan="1">
<italic>48</italic>.<italic>5[42</italic>.<italic>5</italic>,<italic>54]</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>51</italic>.<italic>5[45</italic>,<italic>54]</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>48[44</italic>,<italic>55]</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Follow-up</td><td align="center" rowspan="1" colspan="1">
<italic>53[45</italic>,<italic>54]</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>50[43</italic>,<italic>54]</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>50[43</italic>,<italic>54]</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Fugl-Meyer Lower Limb</bold>
</td><td align="center" rowspan="1" colspan="1">Baseline</td><td align="center" rowspan="1" colspan="1">
<italic>22[18</italic>,<italic>26]</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>21[18</italic>,<italic>28]</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>24[19</italic>,<italic>30]</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Post-treatment</td><td align="center" rowspan="1" colspan="1">
<italic>26[19</italic>,<italic>30</italic>.<italic>5]</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>25[22</italic>.<italic>5</italic>,<italic>31]</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>30[21</italic>,<italic>31]</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Follow-up</td><td align="center" rowspan="1" colspan="1">
<italic>27[19</italic>,<italic>30]</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>26</italic>.<italic>5[21</italic>,<italic>32]</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>29[21</italic>,<italic>31]</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Falls Efficacy Scale</bold>
</td><td align="center" rowspan="1" colspan="1">Baseline</td><td align="center" rowspan="1" colspan="1">
<italic>6</italic>.<italic>3[4</italic>.<italic>1</italic>,<italic>8</italic>.<italic>3]</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>5</italic>.<italic>2</italic>,<italic>9</italic>.<italic>1]</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>5</italic>.<italic>9[4</italic>.<italic>3</italic>,<italic>7</italic>.<italic>6]</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Post-treatment</td><td align="center" rowspan="1" colspan="1">
<italic>6</italic>.<italic>3[4</italic>.<italic>9</italic>,<italic>8</italic>.<italic>9]</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>8</italic>.<italic>1[6</italic>.<italic>8</italic>,<italic>9]</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>7</italic>.<italic>6[5</italic>.<italic>9</italic>,<italic>8</italic>.<italic>3]</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Follow-up</td><td align="center" rowspan="1" colspan="1">
<italic>7</italic>.<italic>9[4</italic>.<italic>5</italic>,<italic>8</italic>.<italic>8]</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>8</italic>.<italic>1[7</italic>.<italic>1</italic>,<italic>9</italic>.<italic>4]</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>6</italic>.<italic>9[5</italic>.<italic>6</italic>,<italic>8]</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>SF&#x02013;12</bold>
</td><td align="center" rowspan="1" colspan="1">Baseline</td><td align="center" rowspan="1" colspan="1">
<italic>27[26</italic>,<italic>30]</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>27[26</italic>,<italic>29]</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>29[28</italic>,<italic>31]</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Post-treatment</td><td align="center" rowspan="1" colspan="1">
<italic>28</italic>.<italic>5[25</italic>.<italic>5</italic>,<italic>33]</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>27[25</italic>,<italic>28]</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>31[26</italic>,<italic>31]</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Follow-up</td><td align="center" rowspan="1" colspan="1">
<italic>30[25</italic>,<italic>32]</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>28[26</italic>,<italic>29]</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>29[24</italic>,<italic>30]</italic>
</td></tr></tbody></table></alternatives></table-wrap><sec id="sec018"><title>Sample size calculation</title><p>With an allocation ratio of 1:1:1 in a three arm trial, a total sample size of 105 participants would be needed to provide 80% power to detect a minimum clinically important difference of (0.16 m/s) (SD = 0.20) [<xref rid="pone.0139261.ref044" ref-type="bibr">44</xref>] in walking speed between any two-group comparison with a 2-sided alpha level of 0.017 allowing for multiple testing.</p></sec></sec><sec sec-type="conclusions" id="sec019"><title>Discussion</title><p>To date few studies have examined interventions which directly address adaptability of gait [<xref rid="pone.0139261.ref010" ref-type="bibr">10</xref>,<xref rid="pone.0139261.ref034" ref-type="bibr">34</xref>,<xref rid="pone.0139261.ref045" ref-type="bibr">45</xref>] and/or the use of visual cues [<xref rid="pone.0139261.ref034" ref-type="bibr">34</xref>,<xref rid="pone.0139261.ref046" ref-type="bibr">46</xref>&#x02013;<xref rid="pone.0139261.ref048" ref-type="bibr">48</xref>] to enhance functional gait recovery following stroke. Evaluation of these aspects of training in the rehabilitation of walking after stroke is important given that many stroke patients are more reliant on vision to control dynamic balance [<xref rid="pone.0139261.ref024" ref-type="bibr">24</xref>]and have difficulty adapting walking, as is necessary in the community.</p><p>This paradigm of visual cue training was selected for investigation based on knowledge of where healthy people look while walking to guide steps [<xref rid="pone.0139261.ref049" ref-type="bibr">49</xref>] and that this gaze behaviour is known to alter in high risk falls groups [<xref rid="pone.0139261.ref050" ref-type="bibr">50</xref>,<xref rid="pone.0139261.ref051" ref-type="bibr">51</xref>]; suggesting gaze is mechanistic in guiding control of steps and visual cues could therefore be an effective treatment paradigm. Our findings indicate that VCT interventions can be feasibly and acceptably delivered within outpatient stroke physiotherapy, as there was generally good adherence to the target treatment frequency. Clinicians reported that patients found stepping to footfall targets compelling and could often achieve improvements in symmetry and speed greater than 10% within one or two sessions. VCT treatments were also safe with only two reports of non-injurious stumbles during treatment. In order to establish feasibility of delivering equivalent intensities of walking practice across treatment arms, we asked therapists to record the time spent actively practicing walking in treatment logs. Pedometers were not used as these tend to undercount the number of steps in people with gait disorders; and this is particularly true for those with low walking speeds [<xref rid="pone.0139261.ref052" ref-type="bibr">52</xref>]. However, our chosen method of recording/monitoring amount of walking practice was not acceptable to therapists as they tended to record the length of the appointment rather than actual duration of walking. More recent studies of activity monitors are showing improved accuracy and reliability in measuring time spent walking in patient groups[<xref rid="pone.0139261.ref053" ref-type="bibr">53</xref>]. Future trials should therefore aim to monitor and measure amount of walking within treatments objectively through the use of activity monitors.</p><p>Withdrawal rates from the study were high and patterns of retention were complex and unequal across treatment arms. We explored potential reasons for this. Similar to other reports of stroke trials of treadmill training [<xref rid="pone.0139261.ref054" ref-type="bibr">54</xref>] and overground walking [<xref rid="pone.0139261.ref055" ref-type="bibr">55</xref>], reasons for non-completion did not reflect the nature of the treatment (i.e. patients did not withdraw because the treatment was unacceptable). Instead, reasons for withdrawal were related to other health problems, changes in social housing, family care arrangements, discharge from rehab services and return to work (see <xref rid="pone.0139261.g002" ref-type="fig">Fig 2</xref>). Those who withdrew tended to be younger and more able than those who completed the course of treatment, suggesting such patients may be less likely to complete treatment because they have more competing demands. Indeed, outpatient based trials of gait training reporting good retention rates (e.g. [<xref rid="pone.0139261.ref056" ref-type="bibr">56</xref>]) tend to involve older, longer-term, less-able participants than our study. Consideration of reported reasons for withdrawal together with characteristics of the populations recruited to trials with good retention indicates outpatient training of gait adaptability may best be targeted towards community-dwelling, chronic stroke survivors with persistent gait impairments [<xref rid="pone.0139261.ref054" ref-type="bibr">54</xref>,<xref rid="pone.0139261.ref056" ref-type="bibr">56</xref>]. Additionally, fewer patients withdrew from UC than VCT treatment arms. In UC, treatment content was not as stringently progressed (based on achievement of targets) or rigorously delivered (based on adherence data). This suggests another way to improve retention could be to offer a maximum number of sessions over a maximum time period, providing flexibility in treatment to accommodate variations in patients&#x02019; ability to attend while still standardising the dose. This method of standardising dose has been shown to be feasible and acceptable in other RCTs of locomotor training and coincides with acceptable rates of attrition [<xref rid="pone.0139261.ref057" ref-type="bibr">57</xref>].</p><p>A greater proportion (20%) of participants were lost to contact in the arms delivered by NHS based services (UC and OVCT) compared to the TVCT (coordinated and delivered by a single research therapist). This drop-out rate is typical of NHS out-patient stroke services and retention of this method of delivery would give a pragmatic reflection of retention in a future Phase III trial. The implications of this retention pattern for future trial design are that in order to optimise retention and give an accurate indication of efficacy all treatment arms should be delivered by a dedicated research therapist at each site, with careful monitoring of contamination (e.g. an online treatment log completion with traffic light monitoring for compliance) and/or regular phone contact from unblinded research team administrators (e.g. secretarial support) to identify and address barriers to adherence/participation as they occur</p><p>We piloted a range of outcome measures including gait speed, symmetry, motor function, balance, fear of falling and mobility. The SF&#x02013;12 was included as a measure of health related quality of life. The feasibility and acceptability of capturing these measures was demonstrated robustly through the wholly complete data sets across all outcome measures for all participants who remained in the study. Future studies should, therefore, continue to use measures spanning body function to participation in order to find out whether improvements in impairment translate to functional outcomes.</p><p>In the absence of established measures of gait adaptability in stroke [<xref rid="pone.0139261.ref058" ref-type="bibr">58</xref>]and given the power of walking speed in reflecting functional outcomes for stroke survivors [<xref rid="pone.0139261.ref028" ref-type="bibr">28</xref>] walking speed would likely remain the primary outcome measure for any future study. Our sample size calculations suggest a total sample size of 105 participants is necessary. With future studies designed to improve retention, a total recruitment of 126 patients (allowing for 20% attrition) would be recommended.</p><p>As feasibility trials are not designed to detect differences between groups, no statistical comparisons between treatments were carried out in this study [<xref rid="pone.0139261.ref025" ref-type="bibr">25</xref>]. The magnitude of positive changes in speed and symmetry are in line with other proof-of-concept studies using different paradigms of visual cueing or practice of variable stepping [<xref rid="pone.0139261.ref010" ref-type="bibr">10</xref>,<xref rid="pone.0139261.ref034" ref-type="bibr">34</xref>,<xref rid="pone.0139261.ref046" ref-type="bibr">46</xref>]. Mean changes in gait speed exceeded minimum detectable changes (MDCs) of 0.18m/s for chronic stroke survivors [<xref rid="pone.0139261.ref044" ref-type="bibr">44</xref>] in the VCT arms but not in UC. However, the changes in gait speed in UC are in line with meta-analyses [<xref rid="pone.0139261.ref059" ref-type="bibr">59</xref>] indicating exercise therapy (including practice of functional tasks associated with walking- which is most comparable to our UC condition) typically leads to speed gains that ranged between 0.04 and 0.20 m/s. All treatment arms showed mean changes in step length and single support symmetry ratios exceeding estimates of MDC (step length = 0.15, and stance time = 0.09) [<xref rid="pone.0139261.ref060" ref-type="bibr">60</xref>]. Further, these improvements in impairments were concomitant with improvements exceeding MDCs in other mobility and balance measures (TUG MDC = 7.84s/28%, BBS MDC = 4.66 points/10% [<xref rid="pone.0139261.ref061" ref-type="bibr">61</xref>]) indicating treatment effects could be considered meaningful. Some measures for some groups (e.g., gait speed for TVCT) improve after training but then get slightly worse again by follow-up highlighting the importance of maintenance for rehabilitation. Other measures (e.g. FAC) appear to continue to improve even after cessation of training. However, changes from post-treatment to follow-up are small and likely not statistically significant. None-the-less, future studies should include at least a 4 week follow-up assessment to robustly investigate time course of change of training effects.</p><sec id="sec020"><title>Limitations and implications for future trial designs</title><p>The primary limitation of this study is the low retention rate at follow up. This indicates a need for future studies to continue in a carefully phased approach; using methods to improve retention, as discussed above, that have been effective in other trials of walking rehabilitation (e.g. offering flexibility in frequency and progression of training), including patients who have been identified in the most recent Cochrane reviews [<xref rid="pone.0139261.ref054" ref-type="bibr">54</xref>] as most likely to benefit from this style of gait training and who, from retention patterns in this trial, are the most able to adhere to treatment, and identifying the best mode of treatment delivery (e.g. treatment delivery by a dedicated research therapist).</p></sec><sec id="sec021"><title>Conclusions</title><p>Gait adaptability training using visual cues after stroke is safe and feasible to deliver within outpatient stroke physiotherapy services. Never-the-less it does not suit all patients and outpatient training of gait adaptability may best be targeted towards community-dwelling, chronic stroke survivors with persistent moderate gait impairments. Future trial designs would be adapted to improve the retention rates at follow up time points.</p></sec></sec><sec sec-type="supplementary-material" id="sec022"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0139261.s001"><label>S1 File</label><caption><title>Full Trial protocol.</title><p>(DOCX)</p></caption><media xlink:href="pone.0139261.s001.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0139261.s002"><label>S2 File</label><caption><title>Published Trial protocol.</title><p>(PDF)</p></caption><media xlink:href="pone.0139261.s002.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0139261.s003"><label>S3 File</label><caption><title>Consort checklist.</title><p>(DOC)</p></caption><media xlink:href="pone.0139261.s003.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0139261.s004"><label>S1 Table</label><caption><title>Means and SD data for change from baseline to post-treatment (8 weeks) and baseline to follow-up (12 weeks) for outcomes of speed, symmetry (step length and single support duration), and time to turn 180 degrees.</title><p>For all measures apart from time to turn and symmetry ratios positive values indicate improvement. For time to turn negative values indicate reduced time to turn and improvement. Symmetry ratios are calculated by dividing the larger of the paretic or non-paretic value (step length or single support time) by the smaller (in accordance with recommendations (Patterson et al, 2010)). Thus a value of 1 represents symmetrical gait and &#x0003e;1 is increasingly asymmetrical. Mean changes with negative values therefore indicate improvements towards a more symmetrical gait.</p><p>(DOCX)</p></caption><media xlink:href="pone.0139261.s004.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>This is a summary of independent research funded by the National Institute for Health Research (NIHR)&#x02019;s Research for Patient Benefit Programme (Grant Reference Number PG-PB-0609-18181). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.</p><p>We would like to thank the hospitals and rehabilitation teams who took part: Moseley Hall Hospital, Royal Leamington Spa Rehabilitation Hospital, Birmingham Heartlands Hospital, Queen Elizabeth Hospital, City and Sandwell Hospital and Solihull Hospital.</p></ack><ref-list><title>References</title><ref id="pone.0139261.ref001"><label>1</label><mixed-citation publication-type="journal">
<name><surname>Hyndman</surname><given-names>D</given-names></name>, <name><surname>Ashburn</surname><given-names>A</given-names></name>, <name><surname>Stack</surname><given-names>E</given-names></name> (<year>2002</year>) <article-title>Fall events among people with stroke living in the community: circumstances of falls and characteristics of fallers</article-title>. <source>Arch Phys Med Rehabil</source>
<volume>83</volume>: <fpage>165</fpage>&#x02013;<lpage>170</lpage>.
<pub-id pub-id-type="pmid">11833018</pub-id></mixed-citation></ref><ref id="pone.0139261.ref002"><label>2</label><mixed-citation publication-type="journal">
<name><surname>Weerdesteyn</surname><given-names>V</given-names></name>, <name><surname>de Niet</surname><given-names>M</given-names></name>, <name><surname>van Duijnhoven</surname><given-names>HJ</given-names></name>, <name><surname>Geurts</surname><given-names>AC</given-names></name> (<year>2008</year>) <article-title>Falls in individuals with stroke</article-title>. <source>J Rehabil Res Dev</source>
<volume>45</volume>: <fpage>1195</fpage>&#x02013;<lpage>1213</lpage>.
<pub-id pub-id-type="pmid">19235120</pub-id></mixed-citation></ref><ref id="pone.0139261.ref003"><label>3</label><mixed-citation publication-type="journal">
<name><surname>Cumming</surname><given-names>RG</given-names></name>, <name><surname>Klineberg</surname><given-names>RJ</given-names></name> (<year>1994</year>) <article-title>Fall frequency and characteristics and the risk of hip fractures</article-title>. <source>J Am Geriatr Soc</source>
<volume>42</volume>: <fpage>774</fpage>&#x02013;<lpage>778</lpage>.
<pub-id pub-id-type="pmid">8014355</pub-id></mixed-citation></ref><ref id="pone.0139261.ref004"><label>4</label><mixed-citation publication-type="journal">
<name><surname>Nyberg</surname><given-names>L</given-names></name>, <name><surname>Gustafson</surname><given-names>Y</given-names></name> (<year>1995</year>) <article-title>Patient falls in stroke rehabilitation. A challenge to rehabilitation strategies</article-title>. <source>Stroke</source>
<volume>26</volume>: <fpage>838</fpage>&#x02013;<lpage>842</lpage>.
<pub-id pub-id-type="pmid">7740577</pub-id></mixed-citation></ref><ref id="pone.0139261.ref005"><label>5</label><mixed-citation publication-type="journal">
<name><surname>Hollands</surname><given-names>KL</given-names></name>, <name><surname>Hollands</surname><given-names>MA</given-names></name>, <name><surname>Zietz</surname><given-names>D</given-names></name>, <name><surname>Wing</surname><given-names>AM</given-names></name>, <name><surname>Wright</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Kinematics of turning 180 degrees during the timed up and go in stroke survivors with and without falls history</article-title>. <source>Neurorehabil Neural Repair</source>
<volume>24</volume>: <fpage>358</fpage>&#x02013;<lpage>367</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1177/1545968309348508">10.1177/1545968309348508</ext-link></comment>
<pub-id pub-id-type="pmid">19822720</pub-id></mixed-citation></ref><ref id="pone.0139261.ref006"><label>6</label><mixed-citation publication-type="journal">
<name><surname>Hollands</surname><given-names>KL</given-names></name>, <name><surname>van Vliet</surname><given-names>P</given-names></name>, <name><surname>Zietz</surname><given-names>D</given-names></name>, <name><surname>Wing</surname><given-names>A</given-names></name>, <name><surname>Wright</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Stroke-related differences in axial body segment coordination during preplanned and reactive changes in walking direction</article-title>. <source>Exp Brain Res</source>
<volume>202</volume>: <fpage>591</fpage>&#x02013;<lpage>604</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00221-010-2162-1">10.1007/s00221-010-2162-1</ext-link></comment>
<pub-id pub-id-type="pmid">20107979</pub-id></mixed-citation></ref><ref id="pone.0139261.ref007"><label>7</label><mixed-citation publication-type="journal">
<name><surname>Den Otter</surname><given-names>AR</given-names></name>, <name><surname>Geurts</surname><given-names>ACH</given-names></name>, <name><surname>de Haart</surname><given-names>M</given-names></name>, <name><surname>Mulder</surname><given-names>T</given-names></name>, <name><surname>Duysens</surname><given-names>J</given-names></name> (<year>2005</year>) <article-title>Step characteristics during obstacle avoidance in hemiplegic stroke</article-title>. <source>Exp Brain Res</source>
<volume>161</volume>: <fpage>180</fpage>&#x02013;<lpage>192</lpage>.
<pub-id pub-id-type="pmid">15517222</pub-id></mixed-citation></ref><ref id="pone.0139261.ref008"><label>8</label><mixed-citation publication-type="journal">
<name><surname>van Swigchem</surname><given-names>R</given-names></name>, <name><surname>van Duijnhoven</surname><given-names>HJ</given-names></name>, <name><surname>den Boer</surname><given-names>J</given-names></name>, <name><surname>Geurts</surname><given-names>AC</given-names></name>, <name><surname>Weerdesteyn</surname><given-names>V</given-names></name> (<year>2013</year>) <article-title>Deficits in motor response to avoid sudden obstacles during gait in functional walkers poststroke</article-title>. <source>Neurorehabil Neural Repair</source>
<volume>27</volume>: <fpage>230</fpage>&#x02013;<lpage>239</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1177/1545968312462070">10.1177/1545968312462070</ext-link></comment>
<pub-id pub-id-type="pmid">23077147</pub-id></mixed-citation></ref><ref id="pone.0139261.ref009"><label>9</label><mixed-citation publication-type="journal">
<name><surname>Said</surname><given-names>CM</given-names></name>, <name><surname>Goldie</surname><given-names>PA</given-names></name>, <name><surname>Patla</surname><given-names>AE</given-names></name>, <name><surname>Sparrow</surname><given-names>WA</given-names></name>, <name><surname>Martin</surname><given-names>KE</given-names></name> (<year>1999</year>) <article-title>Obstacle crossing in subjects with stroke</article-title>. <source>Arch Phys Med Rehabil</source>
<volume>80</volume>: <fpage>1054</fpage>&#x02013;<lpage>1059</lpage>.
<pub-id pub-id-type="pmid">10489008</pub-id></mixed-citation></ref><ref id="pone.0139261.ref010"><label>10</label><mixed-citation publication-type="journal">
<name><surname>Holleran</surname><given-names>CL</given-names></name>, <name><surname>Straube</surname><given-names>DD</given-names></name>, <name><surname>Kinnaird</surname><given-names>CR</given-names></name>, <name><surname>Leddy</surname><given-names>AL</given-names></name>, <name><surname>Hornby</surname><given-names>TG</given-names></name> (<year>2014</year>) <article-title>Feasibility and potential efficacy of high-intensity stepping training in variable contexts in subacute and chronic stroke</article-title>. <source>Neurorehabil Neural Repair</source>
<volume>28</volume>: <fpage>643</fpage>&#x02013;<lpage>651</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1177/1545968314521001">10.1177/1545968314521001</ext-link></comment>
<pub-id pub-id-type="pmid">24515925</pub-id></mixed-citation></ref><ref id="pone.0139261.ref011"><label>11</label><mixed-citation publication-type="journal">
<name><surname>Langhorne</surname><given-names>P</given-names></name>, <name><surname>Coupar</surname><given-names>F</given-names></name>, <name><surname>Pollock</surname><given-names>A</given-names></name> (<year>2009</year>) <article-title>Motor recovery after stroke: a systematic review</article-title>. <source>Lancet Neurol</source>
<volume>8</volume>: <fpage>741</fpage>&#x02013;<lpage>754</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S1474-4422(09)70150-4">10.1016/S1474-4422(09)70150-4</ext-link></comment>
<pub-id pub-id-type="pmid">19608100</pub-id></mixed-citation></ref><ref id="pone.0139261.ref012"><label>12</label><mixed-citation publication-type="journal">
<name><surname>French</surname><given-names>B</given-names></name>, <name><surname>Thomas</surname><given-names>LH</given-names></name>, <name><surname>Leathley</surname><given-names>MJ</given-names></name>, <name><surname>Sutton</surname><given-names>CJ</given-names></name>, <name><surname>McAdam</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Repetitive task training for improving functional ability after stroke</article-title>. <source>Cochrane Database Syst Rev</source>: <fpage>CD006073</fpage>
<pub-id pub-id-type="pmid">17943883</pub-id></mixed-citation></ref><ref id="pone.0139261.ref013"><label>13</label><mixed-citation publication-type="journal">
<name><surname>Langhorne</surname><given-names>P</given-names></name>, <name><surname>Bernhardt</surname><given-names>J</given-names></name>, <name><surname>Kwakkel</surname><given-names>G</given-names></name> (<year>2011</year>) <article-title>Stroke rehabilitation</article-title>. <source>Lancet</source>
<volume>377</volume>: <fpage>1693</fpage>&#x02013;<lpage>1702</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0140-6736(11)60325-5">10.1016/S0140-6736(11)60325-5</ext-link></comment>
<pub-id pub-id-type="pmid">21571152</pub-id></mixed-citation></ref><ref id="pone.0139261.ref014"><label>14</label><mixed-citation publication-type="journal">
<name><surname>Schmidt</surname><given-names>RA</given-names></name> (<year>1975</year>) <article-title>A schema theory of discrete motor skill-learning</article-title>. <source>psychol rev</source>
<volume>82</volume>.</mixed-citation></ref><ref id="pone.0139261.ref015"><label>15</label><mixed-citation publication-type="journal">
<name><surname>Schmidt</surname><given-names>RA</given-names></name> (<year>1985</year>) <article-title>The search for invariance in skilled movement behaviour</article-title>. <source>Res Q Exerc Sport</source>
<volume>56</volume>.</mixed-citation></ref><ref id="pone.0139261.ref016"><label>16</label><mixed-citation publication-type="journal">
<name><surname>Wulf</surname><given-names>G</given-names></name> (<year>2007</year>) <article-title>Attentional focus and motor learning: A revieuw of 10 years of research</article-title>. <source>E-Journal Bewegung und Training</source>
<volume>1</volume>: <fpage>4</fpage>&#x02013;<lpage>14</lpage>.</mixed-citation></ref><ref id="pone.0139261.ref017"><label>17</label><mixed-citation publication-type="journal">
<name><surname>van den Brand</surname><given-names>R</given-names></name>, <name><surname>Heutschi</surname><given-names>J</given-names></name>, <name><surname>Barraud</surname><given-names>Q</given-names></name>, <name><surname>DiGiovanna</surname><given-names>J</given-names></name>, <name><surname>Bartholdi</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Restoring voluntary control of locomotion after paralyzing spinal cord injury</article-title>. <source>Science</source>
<volume>336</volume>: <fpage>1182</fpage>&#x02013;<lpage>1185</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.1217416">10.1126/science.1217416</ext-link></comment>
<pub-id pub-id-type="pmid">22654062</pub-id></mixed-citation></ref><ref id="pone.0139261.ref018"><label>18</label><mixed-citation publication-type="journal">
<name><surname>Shah</surname><given-names>PK</given-names></name>, <name><surname>Gerasimenko</surname><given-names>Y</given-names></name>, <name><surname>Shyu</surname><given-names>A</given-names></name>, <name><surname>Lavrov</surname><given-names>I</given-names></name>, <name><surname>Zhong</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Variability in step training enhances locomotor recovery after a spinal cord injury</article-title>. <source>Eur J Neurosci</source>
<volume>36</volume>: <fpage>2054</fpage>&#x02013;<lpage>2062</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1460-9568.2012.08106.x">10.1111/j.1460-9568.2012.08106.x</ext-link></comment>
<pub-id pub-id-type="pmid">22591277</pub-id></mixed-citation></ref><ref id="pone.0139261.ref019"><label>19</label><mixed-citation publication-type="journal">
<name><surname>Shea</surname><given-names>CHaGW</given-names></name> (<year>1999</year>) <article-title>Enhancing motor learning through external-focus instructions and feedback</article-title>. <source>Human Movement Science</source>
<volume>18</volume>: <fpage>553</fpage>&#x02013;<lpage>571</lpage>.</mixed-citation></ref><ref id="pone.0139261.ref020"><label>20</label><mixed-citation publication-type="journal">
<name><surname>Hollands</surname><given-names>KL</given-names></name>, <name><surname>Pelton</surname><given-names>TA</given-names></name>, <name><surname>Tyson</surname><given-names>SF</given-names></name>, <name><surname>Hollands</surname><given-names>MA</given-names></name>, <name><surname>van Vliet</surname><given-names>PM</given-names></name> (<year>2012</year>) <article-title>Interventions for coordination of walking following stroke: systematic review</article-title>. <source>Gait Posture</source>
<volume>35</volume>: <fpage>349</fpage>&#x02013;<lpage>359</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.gaitpost.2011.10.355">10.1016/j.gaitpost.2011.10.355</ext-link></comment>
<pub-id pub-id-type="pmid">22094228</pub-id></mixed-citation></ref><ref id="pone.0139261.ref021"><label>21</label><mixed-citation publication-type="journal">
<name><surname>Hollands</surname><given-names>MA</given-names></name>, <name><surname>Patla</surname><given-names>AE</given-names></name>, <name><surname>Vickers</surname><given-names>JN</given-names></name> (<year>2002</year>) <article-title>"Look where you're going!": gaze behaviour associated with maintaining and changing the direction of locomotion</article-title>. <source>Exp Brain Res</source>
<volume>143</volume>: <fpage>221</fpage>&#x02013;<lpage>230</lpage>.
<pub-id pub-id-type="pmid">11880898</pub-id></mixed-citation></ref><ref id="pone.0139261.ref022"><label>22</label><mixed-citation publication-type="journal">
<name><surname>Patla</surname><given-names>AE</given-names></name>, <name><surname>Vickers</surname><given-names>JN</given-names></name> (<year>1997</year>) <article-title>Where and when do we look as we approach and step over an obstacle in the travel path?</article-title>
<source>Neuroreport</source>
<volume>8</volume>: <fpage>3661</fpage>&#x02013;<lpage>3665</lpage>.
<pub-id pub-id-type="pmid">9427347</pub-id></mixed-citation></ref><ref id="pone.0139261.ref023"><label>23</label><mixed-citation publication-type="journal">
<name><surname>Bank</surname><given-names>PJ</given-names></name>, <name><surname>Roerdink</surname><given-names>M</given-names></name>, <name><surname>Peper</surname><given-names>CE</given-names></name> (<year>2011</year>) <article-title>Comparing the efficacy of metronome beeps and stepping stones to adjust gait: steps to follow!</article-title>
<source>Exp Brain Res</source>
<volume>209</volume>: <fpage>159</fpage>&#x02013;<lpage>169</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00221-010-2531-9">10.1007/s00221-010-2531-9</ext-link></comment>
<pub-id pub-id-type="pmid">21221956</pub-id></mixed-citation></ref><ref id="pone.0139261.ref024"><label>24</label><mixed-citation publication-type="journal">
<name><surname>Bonan</surname><given-names>IV</given-names></name>, <name><surname>Yelnik</surname><given-names>AP</given-names></name>, <name><surname>Colle</surname><given-names>FM</given-names></name>, <name><surname>Michaud</surname><given-names>C</given-names></name>, <name><surname>Normand</surname><given-names>E</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Reliance on visual information after stroke. Part II: Effectiveness of a balance rehabilitation program with visual cue deprivation after stroke: a randomized controlled trial</article-title>. <source>Arch Phys Med Rehabil</source>
<volume>85</volume>: <fpage>274</fpage>&#x02013;<lpage>278</lpage>.
<pub-id pub-id-type="pmid">14966713</pub-id></mixed-citation></ref><ref id="pone.0139261.ref025"><label>25</label><mixed-citation publication-type="journal">
<name><surname>Lancaster</surname><given-names>GA</given-names></name>, <name><surname>Dodd</surname><given-names>S</given-names></name> (<year>2002</year>) <article-title>Design and Analysis of Pilot Studies: recommendations for good practice</article-title>. <source>J Eval Clin Pract</source>
<volume>10</volume>: <fpage>307</fpage>&#x02013;<lpage>312</lpage>.</mixed-citation></ref><ref id="pone.0139261.ref026"><label>26</label><mixed-citation publication-type="journal">
<name><surname>Craig</surname><given-names>P</given-names></name>, <name><surname>Dieppe</surname><given-names>P</given-names></name>, <name><surname>Macintyre</surname><given-names>S</given-names></name>, <name><surname>Michie</surname><given-names>S</given-names></name>, <name><surname>Nazareth</surname><given-names>I</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Developing and evaluating complex interventions: the new Medical Research Council guidance</article-title>. <source>BMJ</source>
<volume>337</volume>: <fpage>a1655</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/bmj.a1655">10.1136/bmj.a1655</ext-link></comment>
<pub-id pub-id-type="pmid">18824488</pub-id></mixed-citation></ref><ref id="pone.0139261.ref027"><label>27</label><mixed-citation publication-type="journal">
<name><surname>Hollands</surname><given-names>k</given-names></name>, <name><surname>Pelton</surname><given-names>T</given-names></name>, <name><surname>Wimperis</surname><given-names>A</given-names></name>, <name><surname>Whitham</surname><given-names>D</given-names></name>, <name><surname>Jowett</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Visual cue training to improve walking and turning after stroke: a study protocol for a multi-centre, single blind randomised pilot trial</article-title>. <source>Trails</source> 2013 <volume>14</volume>.</mixed-citation></ref><ref id="pone.0139261.ref028"><label>28</label><mixed-citation publication-type="journal">
<name><surname>Perry</surname><given-names>J</given-names></name>, <name><surname>Garrett</surname><given-names>M</given-names></name>, <name><surname>Gronley</surname><given-names>JK</given-names></name>, <name><surname>Mulroy</surname><given-names>SJ</given-names></name> (<year>1995</year>) <article-title>Classification of walking handicap in the stroke population</article-title>. <source>Stroke</source>
<volume>26</volume>: <fpage>982</fpage>&#x02013;<lpage>989</lpage>.
<pub-id pub-id-type="pmid">7762050</pub-id></mixed-citation></ref><ref id="pone.0139261.ref029"><label>29</label><mixed-citation publication-type="journal">
<name><surname>Gladstone</surname><given-names>DJ</given-names></name>, <name><surname>Danells</surname><given-names>CJ</given-names></name>, <name><surname>Black</surname><given-names>SE</given-names></name> (<year>2002</year>) <article-title>The fugl-meyer assessment of motor recovery after stroke: a critical review of its measurement properties</article-title>. <source>Neurorehabil Neural Repair</source>
<volume>16</volume>: <fpage>232</fpage>&#x02013;<lpage>240</lpage>.
<pub-id pub-id-type="pmid">12234086</pub-id></mixed-citation></ref><ref id="pone.0139261.ref030"><label>30</label><mixed-citation publication-type="journal">
<name><surname>Wilson</surname><given-names>JTL</given-names></name>, <name><surname>Hareendran</surname><given-names>A</given-names></name>, <name><surname>Hendry</surname><given-names>A</given-names></name>, <name><surname>Potter</surname><given-names>J</given-names></name>, <name><surname>Bone</surname><given-names>I</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Reliability of the modified Rankin Scale across multiple raters: benefits of a structured interview</article-title>. <source>Stroke</source>
<volume>36</volume>: <fpage>777</fpage>&#x02013;<lpage>781</lpage>.
<pub-id pub-id-type="pmid">15718510</pub-id></mixed-citation></ref><ref id="pone.0139261.ref031"><label>31</label><mixed-citation publication-type="journal">
<name><surname>Holden</surname><given-names>MK</given-names></name>, <name><surname>Gill</surname><given-names>KM</given-names></name>, <name><surname>Magliozzi</surname><given-names>MR</given-names></name> (<year>1986</year>) <article-title>Gait assessment for neurologically impaired patients. Standards for outcome assessment</article-title>. <source>Phys Ther</source>
<volume>66</volume>: <fpage>1530</fpage>&#x02013;<lpage>1539</lpage>.
<pub-id pub-id-type="pmid">3763704</pub-id></mixed-citation></ref><ref id="pone.0139261.ref032"><label>32</label><mixed-citation publication-type="journal">
<name><surname>Folstein</surname><given-names>MF</given-names></name>, <name><surname>Folstein</surname><given-names>SE</given-names></name>, <name><surname>McHugh</surname><given-names>PR</given-names></name> (<year>1975</year>) <article-title>"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician</article-title>. <source>J Psychiatr Res</source>
<volume>12</volume>: <fpage>189</fpage>&#x02013;<lpage>198</lpage>.
<pub-id pub-id-type="pmid">1202204</pub-id></mixed-citation></ref><ref id="pone.0139261.ref033"><label>33</label><mixed-citation publication-type="journal">
<name><surname>Bickerton</surname><given-names>WL</given-names></name>, <name><surname>Samson</surname><given-names>D</given-names></name>, <name><surname>Williamson</surname><given-names>J</given-names></name>, <name><surname>Humphreys</surname><given-names>GW</given-names></name> (<year>2011</year>) <article-title>Separating forms of neglect using the Apples Test: validation and functional prediction in chronic and acute stroke</article-title>. <source>Neuropsychology</source>
<volume>25</volume>: <fpage>567</fpage>&#x02013;<lpage>580</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1037/a0023501">10.1037/a0023501</ext-link></comment>
<pub-id pub-id-type="pmid">21574718</pub-id></mixed-citation></ref><ref id="pone.0139261.ref034"><label>34</label><mixed-citation publication-type="journal">
<name><surname>Heeren</surname><given-names>A</given-names></name>, <name><surname>van Ooijen</surname><given-names>M</given-names></name>, <name><surname>Geurts</surname><given-names>AC</given-names></name>, <name><surname>Day</surname><given-names>BL</given-names></name>, <name><surname>Janssen</surname><given-names>TW</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Step by step: a proof of concept study of C-Mill gait adaptability training in the chronic phase after stroke</article-title>. <source>J Rehabil Med</source>
<volume>45</volume>: <fpage>616</fpage>&#x02013;<lpage>622</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2340/16501977-1180">10.2340/16501977-1180</ext-link></comment>
<pub-id pub-id-type="pmid">23811818</pub-id></mixed-citation></ref><ref id="pone.0139261.ref035"><label>35</label><mixed-citation publication-type="book">
<name><surname>D S</surname></name> (<year>1993</year>) <source>Sheffield Screening Test for Acquired Language Disorders</source>. <publisher-loc>Windsor</publisher-loc>: <publisher-name>NFER-NELSON</publisher-name>.</mixed-citation></ref><ref id="pone.0139261.ref036"><label>36</label><mixed-citation publication-type="journal">
<name><surname>Bilney</surname><given-names>B</given-names></name>, <name><surname>Morris</surname><given-names>M</given-names></name>, <name><surname>Webster</surname><given-names>K</given-names></name> (<year>2002</year>) <article-title>Concurrent related validity of the GAITRite walkway system for quantification of the spatial and temporal parameters of gait</article-title>. <source>Gait Posture</source>
<volume>17</volume>: <fpage>6</fpage>.</mixed-citation></ref><ref id="pone.0139261.ref037"><label>37</label><mixed-citation publication-type="journal">
<name><surname>Yardley</surname><given-names>L</given-names></name>, <name><surname>Beyer</surname><given-names>N</given-names></name>, <name><surname>Hauer</surname><given-names>K</given-names></name>, <name><surname>Kempen</surname><given-names>G</given-names></name>, <name><surname>Piot-Ziegler</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Development and initial validation of the Falls Efficacy Scale-International (FES-I)</article-title>. <source>Age Ageing</source>
<volume>34</volume>: <fpage>614</fpage>&#x02013;<lpage>619</lpage>.
<pub-id pub-id-type="pmid">16267188</pub-id></mixed-citation></ref><ref id="pone.0139261.ref038"><label>38</label><mixed-citation publication-type="journal">
<name><surname>Brazier</surname><given-names>JE</given-names></name>, <name><surname>Harper</surname><given-names>R</given-names></name>, <name><surname>Jones</surname><given-names>NM</given-names></name>, <name><surname>O'Cathain</surname><given-names>A</given-names></name>, <name><surname>Thomas</surname><given-names>KJ</given-names></name>, <etal>et al</etal> (<year>1992</year>) <article-title>Validating the SF&#x02013;36 health survey questionnaire: new outcome measure for primary care</article-title>. <source>BMJ</source>
<volume>305</volume>: <fpage>160</fpage>&#x02013;<lpage>164</lpage>.
<pub-id pub-id-type="pmid">1285753</pub-id></mixed-citation></ref><ref id="pone.0139261.ref039"><label>39</label><mixed-citation publication-type="journal">
<name><surname>Brazier</surname><given-names>JE</given-names></name>, <name><surname>Roberts</surname><given-names>J</given-names></name> (<year>2004</year>) <article-title>The estimation of a preference-based measure of health from the SF&#x02013;12</article-title>. <source>Med Care</source>
<volume>42</volume>: <fpage>851</fpage>&#x02013;<lpage>859</lpage>.
<pub-id pub-id-type="pmid">15319610</pub-id></mixed-citation></ref><ref id="pone.0139261.ref040"><label>40</label><mixed-citation publication-type="journal">
<name><surname>Ng</surname><given-names>SS</given-names></name>, <name><surname>Hui-Chan</surname><given-names>CW</given-names></name> (<year>2005</year>) <article-title>The timed up &#x00026; go test: its reliability and association with lower-limb impairments and locomotor capacities in people with chronic stroke</article-title>. <source>Arch Phys Med Rehabil</source>
<volume>86</volume>: <fpage>1641</fpage>&#x02013;<lpage>1647</lpage>.
<pub-id pub-id-type="pmid">16084820</pub-id></mixed-citation></ref><ref id="pone.0139261.ref041"><label>41</label><mixed-citation publication-type="journal">
<name><surname>Balasubramanian</surname><given-names>CK</given-names></name>, <name><surname>Bowden</surname><given-names>MG</given-names></name>, <name><surname>Neptune</surname><given-names>RR</given-names></name>, <name><surname>Kautz</surname><given-names>SA</given-names></name> (<year>2007</year>) <article-title>Relationship between step length asymmetry and walking performance in subjects with chronic hemiparesis</article-title>. <source>Arch Phys Med Rehabil</source>
<volume>88</volume>: <fpage>43</fpage>&#x02013;<lpage>49</lpage>.
<pub-id pub-id-type="pmid">17207674</pub-id></mixed-citation></ref><ref id="pone.0139261.ref042"><label>42</label><mixed-citation publication-type="journal">
<name><surname>Patterson</surname><given-names>SL</given-names></name>, <name><surname>Rodgers</surname><given-names>MM</given-names></name>, <name><surname>Macko</surname><given-names>RF</given-names></name>, <name><surname>Forrester</surname><given-names>LW</given-names></name> (<year>2008</year>) <article-title>Effect of treadmill exercise training on spatial and temporal gait parameters in subjects with chronic stroke: a preliminary report</article-title>. <source>J Rehabil Res Dev</source>
<volume>45</volume>: <fpage>221</fpage>&#x02013;<lpage>228</lpage>.
<pub-id pub-id-type="pmid">18566940</pub-id></mixed-citation></ref><ref id="pone.0139261.ref043"><label>43</label><mixed-citation publication-type="journal">
<name><surname>Lam</surname><given-names>T</given-names></name>, <name><surname>Luttmann</surname><given-names>K</given-names></name> (<year>2009</year>) <article-title>Turning capacity in ambulatory individuals poststroke</article-title>. <source>Am J Phys Med Rehabil</source>
<volume>88</volume>: <fpage>873</fpage>&#x02013;<lpage>883</lpage>; quiz 884&#x02013;876, 946. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/PHM.0b013e3181bc0ddf">10.1097/PHM.0b013e3181bc0ddf</ext-link></comment>
<pub-id pub-id-type="pmid">19893383</pub-id></mixed-citation></ref><ref id="pone.0139261.ref044"><label>44</label><mixed-citation publication-type="journal">
<name><surname>Tilson</surname><given-names>JK</given-names></name>, <name><surname>Sullivan</surname><given-names>KJ</given-names></name>, <name><surname>Cen</surname><given-names>SY</given-names></name>, <name><surname>Rose</surname><given-names>DK</given-names></name>, <name><surname>Koradia</surname><given-names>CH</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Meaningful gait speed improvement during the first 60 days poststroke: minimal clinically important difference</article-title>. <source>Phys Ther</source>
<volume>90</volume>: <fpage>196</fpage>&#x02013;<lpage>208</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2522/ptj.20090079">10.2522/ptj.20090079</ext-link></comment>
<pub-id pub-id-type="pmid">20022995</pub-id></mixed-citation></ref><ref id="pone.0139261.ref045"><label>45</label><mixed-citation publication-type="journal">
<name><surname>Jaffe</surname><given-names>DL</given-names></name>, <name><surname>Brown</surname><given-names>DA</given-names></name>, <name><surname>Pierson-Carey</surname><given-names>CD</given-names></name>, <name><surname>Buckley</surname><given-names>EL</given-names></name>, <name><surname>Lew</surname><given-names>HL</given-names></name> (<year>2004</year>) <article-title>Stepping over obstacles to improve walking in individuals with poststroke hemiplegia</article-title>. <source>J Rehabil Res Dev</source>
<volume>41</volume>: <fpage>283</fpage>&#x02013;<lpage>292</lpage>.
<pub-id pub-id-type="pmid">15543446</pub-id></mixed-citation></ref><ref id="pone.0139261.ref046"><label>46</label><mixed-citation publication-type="journal">
<name><surname>Lewek</surname><given-names>MD</given-names></name>, <name><surname>Feasel</surname><given-names>J</given-names></name>, <name><surname>Wentz</surname><given-names>E</given-names></name>, <name><surname>Brooks</surname><given-names>FP</given-names><suffix>Jr.</suffix></name>, <name><surname>Whitton</surname><given-names>MC</given-names></name> (<year>2012</year>) <article-title>Use of visual and proprioceptive feedback to improve gait speed and spatiotemporal symmetry following chronic stroke: a case series</article-title>. <source>Phys Ther</source>
<volume>92</volume>: <fpage>748</fpage>&#x02013;<lpage>756</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2522/ptj.20110206">10.2522/ptj.20110206</ext-link></comment>
<pub-id pub-id-type="pmid">22228605</pub-id></mixed-citation></ref><ref id="pone.0139261.ref047"><label>47</label><mixed-citation publication-type="journal">
<name><surname>Kang</surname><given-names>H-K</given-names></name>, <name><surname>Kim</surname><given-names>Y</given-names></name>, <name><surname>Chung</surname><given-names>Y</given-names></name>, <name><surname>Hwang</surname><given-names>S</given-names></name> (<year>2012</year>) <article-title>Effects of treadmill training with optic flow on balance and gait in individuals following stroke: randomized controlled trials</article-title>. <source>Clin Rehabil</source>
<volume>26</volume>: <fpage>246</fpage>&#x02013;<lpage>255</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1177/0269215511419383">10.1177/0269215511419383</ext-link></comment>
<pub-id pub-id-type="pmid">21971754</pub-id></mixed-citation></ref><ref id="pone.0139261.ref048"><label>48</label><mixed-citation publication-type="journal">
<name><surname>Yang</surname><given-names>S</given-names></name>, <name><surname>Hwang</surname><given-names>W-H</given-names></name>, <name><surname>Tsai</surname><given-names>Y-C</given-names></name>, <name><surname>Liu</surname><given-names>F-K</given-names></name>, <name><surname>Hsieh</surname><given-names>L-F</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Improving balance skills in patients who had stroke through virtual reality treadmill training</article-title>. <source>Am J Phys Med Rehabil</source>
<volume>90</volume>: <fpage>969</fpage>&#x02013;<lpage>978</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/PHM.0b013e3182389fae">10.1097/PHM.0b013e3182389fae</ext-link></comment>
<pub-id pub-id-type="pmid">22019971</pub-id></mixed-citation></ref><ref id="pone.0139261.ref049"><label>49</label><mixed-citation publication-type="journal">
<name><surname>Hollands</surname><given-names>MA</given-names></name>, <name><surname>Marple-Horvat</surname><given-names>DE</given-names></name> (<year>2001</year>) <article-title>Coordination of eye and leg movements during visually guided stepping</article-title>. <source>J Mot Behav</source>
<volume>33</volume>: <fpage>205</fpage>&#x02013;<lpage>216</lpage>.
<pub-id pub-id-type="pmid">11404215</pub-id></mixed-citation></ref><ref id="pone.0139261.ref050"><label>50</label><mixed-citation publication-type="journal">
<name><surname>Young</surname><given-names>WR</given-names></name>, <name><surname>Hollands</surname><given-names>MA</given-names></name> (<year>2012</year>) <article-title>Newly acquired fear of falling leads to altered eye movement patterns and reduced stepping safety: a case study</article-title>. <source>PLoS One</source>
<volume>7</volume>: <fpage>e49765</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0049765">10.1371/journal.pone.0049765</ext-link></comment>
<pub-id pub-id-type="pmid">23185432</pub-id></mixed-citation></ref><ref id="pone.0139261.ref051"><label>51</label><mixed-citation publication-type="journal">
<name><surname>Young</surname><given-names>WR</given-names></name>, <name><surname>Hollands</surname><given-names>MA</given-names></name> (<year>2010</year>) <article-title>Can telling older adults where to look reduce falls? Evidence for a causal link between inappropriate visual sampling and suboptimal stepping performance</article-title>. <source>Exp Brain Res</source>
<volume>204</volume>: <fpage>103</fpage>&#x02013;<lpage>113</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00221-010-2300-9">10.1007/s00221-010-2300-9</ext-link></comment>
<pub-id pub-id-type="pmid">20512484</pub-id></mixed-citation></ref><ref id="pone.0139261.ref052"><label>52</label><mixed-citation publication-type="journal">
<name><surname>Cyarto</surname><given-names>EV</given-names></name>, <name><surname>Myers</surname><given-names>AM</given-names></name>, <name><surname>Tudor-Locke</surname><given-names>C</given-names></name> (<year>2004</year>) <article-title>Pedometer accuracy in nursing home and community-dwelling older adults</article-title>. <source>Med Sci Sports Exerc</source>
<volume>36</volume>: <fpage>205</fpage>&#x02013;<lpage>209</lpage>.
<pub-id pub-id-type="pmid">14767241</pub-id></mixed-citation></ref><ref id="pone.0139261.ref053"><label>53</label><mixed-citation publication-type="journal">
<name><surname>Taraldsen</surname><given-names>K</given-names></name>, <name><surname>Chastin</surname><given-names>SF</given-names></name>, <name><surname>Riphagen</surname><given-names>II</given-names></name>, <name><surname>Vereijken</surname><given-names>B</given-names></name>, <name><surname>Helbostad</surname><given-names>JL</given-names></name> (<year>2012</year>) <article-title>Physical activity monitoring by use of accelerometer-based body-worn sensors in older adults: a systematic literature review of current knowledge and applications</article-title>. <source>Maturitas</source>
<volume>71</volume>: <fpage>13</fpage>&#x02013;<lpage>19</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.maturitas.2011.11.003">10.1016/j.maturitas.2011.11.003</ext-link></comment>
<pub-id pub-id-type="pmid">22134002</pub-id></mixed-citation></ref><ref id="pone.0139261.ref054"><label>54</label><mixed-citation publication-type="journal">
<name><surname>Merholz</surname><given-names>J. P, M.</given-names></name>, <name><surname>Elsner</surname><given-names>B.</given-names></name> (<year>2014</year>) <article-title>Treadmill training and body weight support for walking after stroke</article-title>. <source>Cochrane Database Syst Rev</source>
<volume>23</volume>: <fpage>CD002840</fpage>.</mixed-citation></ref><ref id="pone.0139261.ref055"><label>55</label><mixed-citation publication-type="journal">
<name><surname>States</surname><given-names>R.A. SY</given-names></name>, <name><surname>Pappas</surname><given-names>E</given-names></name>. (<year>2009</year>) <article-title>Overground gait training for individuals with chronic stroke: a Cochrane systematic review</article-title>. <source>J Neurol Phys Ther</source>
<volume>33</volume>: <fpage>179</fpage>&#x02013;<lpage>186</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/NPT.0b013e3181c29a8c">10.1097/NPT.0b013e3181c29a8c</ext-link></comment>
<pub-id pub-id-type="pmid">20208461</pub-id></mixed-citation></ref><ref id="pone.0139261.ref056"><label>56</label><mixed-citation publication-type="journal">
<name><surname>Ada</surname><given-names>L DC</given-names></name>, <name><surname>Lindley</surname><given-names>R</given-names></name> (<year>2013</year>) <article-title>Randomized trial of treadmill training to improve walking in community-dwelling people after stroke: the AMBULATE trial</article-title>. <source>Int J Stroke</source>
<volume>8</volume>: <fpage>436</fpage>&#x02013;<lpage>444</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1747-4949.2012.00934.x">10.1111/j.1747-4949.2012.00934.x</ext-link></comment>
<pub-id pub-id-type="pmid">23464674</pub-id></mixed-citation></ref><ref id="pone.0139261.ref057"><label>57</label><mixed-citation publication-type="journal">
<name><surname>Duncan</surname><given-names>PW SK</given-names></name>, <name><surname>Behrman</surname><given-names>AL</given-names></name>, <name><surname>Azen</surname><given-names>SP</given-names></name>, <name><surname>Wu</surname><given-names>SS</given-names></name>, <name><surname>Nadeau</surname><given-names>SE</given-names></name>, <name><surname>Dobkin</surname><given-names>BH</given-names></name>, <name><surname>Rose</surname><given-names>DK</given-names></name>, <name><surname>Tilson</surname><given-names>JK</given-names></name>, <name><surname>Cen</surname><given-names>S</given-names></name>, <name><surname>Hayden</surname><given-names>SK</given-names></name>; <collab>LEAPS Investigative Team</collab> (<year>2011</year>) <article-title>Body-weight-supported treadmill rehabilitation after stroke</article-title>. <source>N Engl J Med</source>
<volume>364</volume>: <fpage>2026</fpage>&#x02013;<lpage>2036</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMoa1010790">10.1056/NEJMoa1010790</ext-link></comment>
<pub-id pub-id-type="pmid">21612471</pub-id></mixed-citation></ref><ref id="pone.0139261.ref058"><label>58</label><mixed-citation publication-type="journal">
<name><surname>Balasubramanian</surname><given-names>CK</given-names></name>, <name><surname>Clark</surname><given-names>DJ</given-names></name>, <name><surname>Fox</surname><given-names>EJ</given-names></name> (<year>2014</year>) <article-title>Walking adaptability after a stroke and its assessment in clinical settings</article-title>. <source>Stroke Res Treat</source>
<volume>2014</volume>: <fpage>591013</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1155/2014/591013">10.1155/2014/591013</ext-link></comment>
<pub-id pub-id-type="pmid">25254140</pub-id></mixed-citation></ref><ref id="pone.0139261.ref059"><label>59</label><mixed-citation publication-type="journal">
<name><surname>Dickstein</surname><given-names>R</given-names></name> (<year>2008</year>) <article-title>Rehabilitation of gait speed after stroke: a critical review of intervention approaches</article-title>. <source>Neurorehabil Neural Repair</source>
<volume>22</volume>: <fpage>649</fpage>&#x02013;<lpage>660</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1177/15459683080220060201">10.1177/15459683080220060201</ext-link></comment>
<pub-id pub-id-type="pmid">18971380</pub-id></mixed-citation></ref><ref id="pone.0139261.ref060"><label>60</label><mixed-citation publication-type="journal">
<name><surname>Lewek</surname><given-names>MD</given-names></name>, <name><surname>Randall</surname><given-names>EP</given-names></name> (<year>2011</year>) <article-title>Reliability of spatiotemporal asymmetry during overground walking for individuals following chronic stroke</article-title>. <source>J Neurol Phys Ther</source>
<volume>35</volume>: <fpage>116</fpage>&#x02013;<lpage>121</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/NPT.0b013e318227fe70">10.1097/NPT.0b013e318227fe70</ext-link></comment>
<pub-id pub-id-type="pmid">21934372</pub-id></mixed-citation></ref><ref id="pone.0139261.ref061"><label>61</label><mixed-citation publication-type="journal">
<name><surname>Hiengkaew</surname><given-names>V</given-names></name>, <name><surname>Jitaree</surname><given-names>K</given-names></name>, <name><surname>Chaiyawat</surname><given-names>P</given-names></name> (<year>2012</year>) <article-title>Minimal detectable changes of the Berg Balance Scale, Fugl-Meyer Assessment Scale, Timed "Up &#x00026; Go" Test, gait speeds, and 2-minute walk test in individuals with chronic stroke with different degrees of ankle plantarflexor tone</article-title>. <source>Arch Phys Med Rehabil</source>
<volume>93</volume>: <fpage>1201</fpage>&#x02013;<lpage>1208</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.apmr.2012.01.014">10.1016/j.apmr.2012.01.014</ext-link></comment>
<pub-id pub-id-type="pmid">22502805</pub-id></mixed-citation></ref></ref-list></back></article>